☰

John D. Baxter, M.D. - Publications

Affiliations: 
University of California, San Francisco, San Francisco, CA 
Tree Info Similar researchers PubMed Report error

186/358 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Lin JZ, Martagón AJ, Cimini SL, Gonzalez DD, Tinkey DW, Biter A, Baxter JD, Webb P, Gustafsson JÅ, Hartig SM, Phillips KJ. Pharmacological Activation of Thyroid Hormone Receptors Elicits a Functional Conversion of White to Brown Fat. Cell Reports. PMID 26586443 DOI: 10.1016/J.Celrep.2015.10.022  0.369
2014 Arulsundaram VD, Webb P, Yousef AF, Pelka P, Fonseca GJ, Baxter JD, Walfish PG, Mymryk JS. The adenovirus 55 residue E1A protein is a transcriptional activator and binds the unliganded thyroid hormone receptor. The Journal of General Virology. 95: 142-52. PMID 24136366 DOI: 10.1099/Vir.0.056838-0  0.377
2013 Yuan C, Nguyen P, Baxter JD, Webb P. Distinct ligand-dependent and independent modes of thyroid hormone receptor (TR)/PGC-1α interaction. The Journal of Steroid Biochemistry and Molecular Biology. 133: 58-65. PMID 22974658 DOI: 10.1016/J.Jsbmb.2012.09.001  0.379
2012 Lin JZ, Martagón AJ, Hsueh WA, Baxter JD, Gustafsson JÅ, Webb P, Phillips KJ. Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor. Endocrinology. 153: 6136-44. PMID 23087171 DOI: 10.1210/En.2011-2081  0.376
2012 Grosdidier S, Carbó LR, Buzón V, Brooke G, Nguyen P, Baxter JD, Bevan C, Webb P, Estébanez-Perpiñá E, Fernández-Recio J. Allosteric conversation in the androgen receptor ligand-binding domain surfaces Molecular Endocrinology. 26: 1078-1090. PMID 22653923 DOI: 10.1210/Me.2011-1281  0.362
2012 Amato AA, Rajagopalan S, Lin JZ, Carvalho BM, Figueira AC, Lu J, Ayers SD, Mottin M, Silveira RL, Souza PC, Mourão RH, Saad MJ, Togashi M, Simeoni LA, Abdalla DS, ... ... Baxter JD, et al. GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain. The Journal of Biological Chemistry. 287: 28169-79. PMID 22584573 DOI: 10.1074/Jbc.M111.332106  0.337
2012 Xiao R, Sun D, Ayers S, Xi Y, Li W, Baxter JD, Moore DD. Research resource: The estrogen receptor α cistrome defined by damIP Molecular Endocrinology. 26: 349-357. PMID 22207717 DOI: 10.1210/Me.2011-1080  0.416
2012 Yumoto F, Nguyen P, Sablin EP, Baxter JD, Webb P, Fletterick RJ. Structural basis of coactivation of liver receptor homolog-1 by β-catenin. Proceedings of the National Academy of Sciences of the United States of America. 109: 143-8. PMID 22187462 DOI: 10.1073/Pnas.1117036108  0.396
2012 Yuan C, Lin JZH, Sieglaff DH, Ayers SD, DeNoto-Reynolds F, Baxter JD, Webb P. Identical gene regulation patterns of T 3and selective thyroid hormone receptor modulator GC-1 Endocrinology. 153: 501-511. PMID 22067320 DOI: 10.1210/En.2011-1325  0.42
2011 Saunier EF, Vivar OI, Rubenstein A, Zhao X, Olshansky M, Baggett S, Staub RE, Tagliaferri M, Cohen I, Speed TP, Baxter JD, Leitman DC. Estrogenic plant extracts reverse weight gain and fat accumulation without causing mammary gland or uterine proliferation. Plos One. 6: e28333. PMID 22163294 DOI: 10.1371/Journal.Pone.0028333  0.322
2011 Figueira ACM, Saidemberg DM, Souza PCT, Martínez L, Scanlan TS, Baxter JD, Skaf MS, Palma MS, Webb P, Polikarpov I. Analysis of agonist and antagonist effects on thyroid hormone receptor conformation by hydrogen/deuterium exchange Molecular Endocrinology. 25: 15-31. PMID 21106879 DOI: 10.1210/Me.2010-0202  0.378
2009 Martínez L, Nascimento AS, Nunes FM, Phillips K, Aparicio R, Dias SMG, Figueira ACM, Lin JH, Nguyen P, Apriletti JW, Neves FAR, Baxter JD, Webb P, Skaf MS, Polikarpov I. Gaining ligand selectivity in thyroid hormone receptors via entropy Proceedings of the National Academy of Sciences of the United States of America. 106: 20717-20722. PMID 19926848 DOI: 10.1073/Pnas.0911024106  0.406
2009 Govindan M, Meng X, Denis CL, Webb P, Baxter JD, Walfish PG. Identification of CCR4 and other essential thyroid hormone receptor co-activators by modified yeast synthetic genetic array analysis. Proceedings of the National Academy of Sciences of the United States of America. 106: 19854-9. PMID 19903885 DOI: 10.1073/Pnas.0910134106  0.432
2009 Cunha Lima ST, Nguyen NH, Togashi M, Apriletti JW, Nguyen P, Polikarpov I, Scanlan TS, Baxter JD, Webb P. Differential effects of TR ligands on hormone dissociation rates: Evidence for multiple ligand entry/exit pathways Journal of Steroid Biochemistry and Molecular Biology. 117: 125-131. PMID 19729063 DOI: 10.1016/J.Jsbmb.2009.08.003  0.406
2009 Baxter JD, Webb P. Thyroid hormone mimetics: Potential applications in atherosclerosis, obesity and type 2 diabetes Nature Reviews Drug Discovery. 8: 308-320. PMID 19337272 DOI: 10.1038/Nrd2830  0.31
2009 Jouravel N, Sablin E, Togashi M, Baxter JD, Webb P, Fletterick RJ. Molecular basis for dimer formation of TRbeta variant D355R. Proteins. 75: 111-7. PMID 18798561 DOI: 10.1002/Prot.22225  0.318
2008 Shah V, Nguyen P, Nguyen NH, Togashi M, Scanlan TS, Baxter JD, Webb P. Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines Molecular and Cellular Endocrinology. 296: 69-77. PMID 18930112 DOI: 10.1016/J.Mce.2008.09.016  0.468
2008 Jeyakumar M, Webb P, Baxter JD, Scanlan TS, Katzenellenbogen JA. Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor. Biochemistry. 47: 7465-76. PMID 18558711 DOI: 10.1021/Bi800393U  0.449
2008 Bleicher L, Aparicio R, Nunes FM, Martinez L, Gomes Dias SM, Figueira ACM, Santos MAM, Venturelli WH, Da Silva R, Donate PM, Neves FAR, Simeoni LA, Baxter JD, Webb P, Skaf MS, et al. Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms Bmc Structural Biology. 8. PMID 18237438 DOI: 10.1186/1472-6807-8-8  0.339
2007 Estébanez-Perpiñá E, Arnold LA, Arnold AA, Nguyen P, Rodrigues ED, Mar E, Bateman R, Pallai P, Shokat KM, Baxter JD, Guy RK, Webb P, Fletterick RJ. A surface on the androgen receptor that allosterically regulates coactivator binding. Proceedings of the National Academy of Sciences of the United States of America. 104: 16074-9. PMID 17911242 DOI: 10.1073/Pnas.0708036104  0.408
2007 Estébanez-Perpiñá E, Arnold LA, Jouravel N, Togashi M, Blethrow J, Mar E, Nguyen P, Phillips KJ, Baxter JD, Webb P, Guy RK, Fletterick RJ. Structural insight into the mode of action of a direct inhibitor of coregulator binding to the thyroid hormone receptor. Molecular Endocrinology (Baltimore, Md.). 21: 2919-28. PMID 17823305 DOI: 10.1210/Me.2007-0174  0.351
2007 Velasco LFR, Togashi M, Walfish PG, Pessanha RP, Moura FN, Barra GB, Nguyen P, Rebong R, Yuan C, Simeoni LA, Ribeiro RCJ, Baxter JD, Webb P, Neves FAR. Thyroid hormone response element organization dictates the composition of active receptor Journal of Biological Chemistry. 282: 12458-12466. PMID 17311926 DOI: 10.1074/Jbc.M610700200  0.4
2007 Figueira ACM, Neto MDO, Bernardes A, Dias SMG, Craievich AF, Baxter JD, Webb P, Polikarpov I. Low-resolution structures of thyroid hormone receptor dimers and tetramers in solution Biochemistry. 46: 1273-1283. PMID 17260956 DOI: 10.1021/Bi061698H  0.386
2006 Flamant F, Baxter JD, Forrest D, Refetoff S, Samuels H, Scanlan TS, Vennström B, Samarut J. International union of pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: Thyroid hormone receptors Pharmacological Reviews. 58: 705-711. PMID 17132849 DOI: 10.1124/Pr.58.4.3  0.421
2006 Meng X, Arulsundaram VD, Yousef AF, Webb P, Baxter JD, Mymryk JS, Walfish PG. Corepressor/coactivator paradox: potential constitutive coactivation by corepressor splice variants. Nuclear Receptor Signaling. 4: e022. PMID 17088938 DOI: 10.1621/Nrs.04022  0.407
2006 Arnold LA, Estébanez-Perpiñá E, Togashi M, Shelat A, Ocasio CA, McReynolds AC, Nguyen P, Baxter JD, Fletterick RJ, Webb P, Guy RK. A high-throughput screening method to identify small molecule inhibitors of thyroid hormone receptor coactivator binding. Science's Stke : Signal Transduction Knowledge Environment. 2006: pl3. PMID 16804159 DOI: 10.1126/Stke.3412006Pl3  0.379
2006 Nascimento AS, Dias SMG, Nunes FM, Aparício R, Ambrosio ALB, Bleicher L, Figueira ACM, Santos MAM, Neto MdO, Fischer H, Togashi M, Craievich AF, Garratt RC, Baxter JD, Webb P, et al. Structural Rearrangements in the Thyroid Hormone Receptor Hinge Domain and Their Putative Role in the Receptor Function Journal of Molecular Biology. 360: 586-598. PMID 16781732 DOI: 10.1016/J.Jmb.2006.05.008  0.35
2006 Figueira ACM, Dias SMG, Santos MAM, Apriletti JW, Baxter JD, Webb P, Neves FAR, Simeoni LA, Ribeiro RCJ, Polikarpov I. Human thyroid receptor forms tetramers in solution, which dissociate into dimers upon ligand binding Cell Biochemistry and Biophysics. 44: 453-462. PMID 16679533 DOI: 10.1385/Cbb:44:3:453  0.467
2006 Baxter JD, Webb P. Metabolism: Bile acids heat things up Nature. 439: 402-403. PMID 16437098 DOI: 10.1038/439402A  0.319
2005 Arnold LA, Estébanez-Perpiñá E, Togashi M, Jouravel N, Shelat A, McReynolds AC, Mar E, Nguyen P, Baxter JD, Fletterick RJ, Webb P, Guy RK. Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators. The Journal of Biological Chemistry. 280: 43048-55. PMID 16263725 DOI: 10.1074/Jbc.M506693200  0.445
2005 Gloss B, Giannocco G, Swanson EA, Moriscot AS, Chiellini G, Scanlan T, Baxter JD, Dillmann WH. Different configurations of specific thyroid hormone response elements mediate opposite effects of thyroid hormone and GC-1 on gene expression Endocrinology. 146: 4926-4933. PMID 16081636 DOI: 10.1210/En.2005-0631  0.418
2005 Johansson L, Rudling M, Scanlan TS, Lundåsen T, Webb P, Baxter J, Angelin B, Parini P. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice Proceedings of the National Academy of Sciences of the United States of America. 102: 10297-10302. PMID 16006512 DOI: 10.1073/Pnas.0504379102  0.321
2005 Martínez L, Sonoda MT, Webb P, Baxter JD, Skaf MS, Polikarpov I. Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptors Biophysical Journal. 89: 2011-2023. PMID 15980170 DOI: 10.1529/Biophysj.105.063818  0.38
2005 Togashi M, Nguyen P, Fletterick R, Baxter JD, Webb P. Rearrangements in thyroid hormone receptor charge clusters that stabilize bound 3,5′,5-triiodo-L-thyronine and inhibit homodimer formation Journal of Biological Chemistry. 280: 25665-25673. PMID 15886199 DOI: 10.1074/Jbc.M501615200  0.42
2005 Togashi M, Borngraeber S, Sandler B, Fletterick RJ, Webb P, Baxter JD. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design. The Journal of Steroid Biochemistry and Molecular Biology. 93: 127-37. PMID 15860255 DOI: 10.1016/J.Jsbmb.2005.01.004  0.406
2005 Nguyen NH, Apriletti JW, Baxter JD, Scanlan TS. Hammett analysis of selective thyroid hormone receptor modulators reveals structural and electronic requirements for hormone antagonists Journal of the American Chemical Society. 127: 4599-4608. PMID 15796525 DOI: 10.1021/Ja0440093  0.416
2005 Estébanez-Perpiñá E, Moore JM, Mar E, Delgado-Rodrigues E, Nguyen P, Baxter JD, Buehrer BM, Webb P, Fletterick RJ, Guy RK. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor. The Journal of Biological Chemistry. 280: 8060-8. PMID 15563469 DOI: 10.1074/Jbc.M407046200  0.441
2004 Sandler B, Webb P, Apriletti JW, Huber BR, Togashi M, Cunha Lima ST, Juric S, Nilsson S, Wagner R, Fletterick RJ, Baxter JD. Thyroxine-thyroid hormone receptor interactions. The Journal of Biological Chemistry. 279: 55801-8. PMID 15466465 DOI: 10.1074/Jbc.M410124200  0.369
2004 Nunes FM, Aparicio R, Santos MAM, Portugal RV, Dias SMG, Neves FAR, Simeoni LA, Baxter JD, Webb P, Polikarpov I. Crystallization and preliminary X-ray diffraction studies of isoform α1 of the human thyroid hormone receptor ligand-binding domain Acta Crystallographica Section D: Biological Crystallography. 60: 1867-1870. PMID 15388935 DOI: 10.1107/S0907444904017858  0.394
2004 Baxter JD, Funder JW, Apriletti JW, Webb P. Towards selectively modulating mineralocorticoid receptor function: lessons from other systems. Molecular and Cellular Endocrinology. 217: 151-65. PMID 15134814 DOI: 10.1016/J.Mce.2003.10.044  0.4
2004 Baxter JD, Webb P, Grover G, Scanlan TS. Selective activation of thyroid hormone signaling pathways by GC-1: A new approach to controlling cholesterol and body weight Trends in Endocrinology and Metabolism. 15: 154-157. PMID 15109613 DOI: 10.1016/J.Tem.2004.03.008  0.369
2004 Dupré SM, Guissouma H, Flamant F, Seugnet I, Scanlan TS, Baxter JD, Samarut J, Demeneix BA, Becker N. Both thyroid hormone receptor (TR)β1 and TRβ2 isoforms contribute to the regulation of hypothalamic Thyrotropin-Releasing Hormone Endocrinology. 145: 2337-2345. PMID 14726446 DOI: 10.1210/En.2003-1209  0.383
2004 Grover GJ, Egan DM, Sleph PG, Beehler BC, Chiellini G, Nguyen NH, Baxter JD, Scanlan TS. Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: Selective actions relative to 3,5,3′-triiodo-L-thyronine Endocrinology. 145: 1656-1661. PMID 14701670 DOI: 10.1210/En.2003-0973  0.318
2003 Borngraeber S, Budny MJ, Chiellini G, Cunha-Lima ST, Togashi M, Webb P, Baxter JD, Scanlan TS, Fletterick RJ. Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor. Proceedings of the National Academy of Sciences of the United States of America. 100: 15358-63. PMID 14673100 DOI: 10.1073/Pnas.2136689100  0.476
2003 Webb P, Valentine C, Nguyen P, Price RH, Marimuthu A, West BL, Baxter JD, Kushner PJ. ERbeta Binds N-CoR in the Presence of Estrogens via an LXXLL-like Motif in the N-CoR C-terminus. Nuclear Receptor. 1: 4. PMID 12904255 DOI: 10.1186/1478-1336-1-4  0.401
2003 Huber BR, Sandler B, West BL, Cunha Lima ST, Nguyen HT, Apriletti JW, Baxter JD, Fletterick RJ. Two resistance to thyroid hormone mutants with impaired hormone binding. Molecular Endocrinology (Baltimore, Md.). 17: 643-52. PMID 12554782 DOI: 10.1210/Me.2002-0095  0.459
2003 Fischer H, Dias SM, Santos MA, Alves AC, Zanchin N, Craievich AF, Apriletti JW, Baxter JD, Webb P, Neves FA, Ribeiro RC, Polikarpov I. Low resolution structures of the retinoid X receptor DNA-binding and ligand-binding domains revealed by synchrotron X-ray solution scattering. The Journal of Biological Chemistry. 278: 16030-8. PMID 12533536 DOI: 10.1074/Jbc.M206953200  0.389
2002 Webb P, Nguyen NH, Chiellini G, Yoshihara HA, Cunha Lima ST, Apriletti JW, Ribeiro RC, Marimuthu A, West BL, Goede P, Mellstrom K, Nilsson S, Kushner PJ, Fletterick RJ, Scanlan TS, ... Baxter JD, et al. Design of thyroid hormone receptor antagonists from first principles. The Journal of Steroid Biochemistry and Molecular Biology. 83: 59-73. PMID 12650702 DOI: 10.1016/S0960-0760(02)00270-4  0.412
2002 Nguyen NH, Apriletti JW, Cunha Lima ST, Webb P, Baxter JD, Scanlan TS. Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment. Journal of Medicinal Chemistry. 45: 3310-20. PMID 12109914 DOI: 10.1021/Jm0201013  0.397
2002 Weatherman RV, Chang CY, Clegg NJ, Carroll DC, Day RN, Baxter JD, McDonnell DP, Scanlan TS, Schaufele F. Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transfer. Molecular Endocrinology (Baltimore, Md.). 16: 487-96. PMID 11875107 DOI: 10.1210/Mend.16.3.0813  0.389
2002 Baxter JD, Goede P, Apriletti JW, West BL, Feng W, Mellstrom K, Fletterick RJ, Wagner RL, Kushner PJ, Ribeiro RC, Webb P, Scanlan TS, Nilsson S. Structure-based design and synthesis of a thyroid hormone receptor (TR) antagonist. Endocrinology. 143: 517-24. PMID 11796506 DOI: 10.1210/Endo.143.2.8617  0.449
2001 Yoshihara HA, Apriletti JW, Baxter JD, Scanlan TS. A designed antagonist of the thyroid hormone receptor. Bioorganic & Medicinal Chemistry Letters. 11: 2821-5. PMID 11597408 DOI: 10.1016/S0960-894X(01)00521-2  0.335
2001 Kinugawa K, Yonekura K, Ribeiro RCJ, Eto Y, Aoyagi T, Baxter JD, Camacho SA, Bristow MR, Long CS, Simpson PC. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy Circulation Research. 89: 591-598. PMID 11577024 DOI: 10.1161/Hh1901.096706  0.35
2001 Baxter JD, Dillmann WH, West BL, Huber R, Furlow JD, Fletterick RJ, Webb P, Apriletti JW, Scanlan TS. Selective modulation of thyroid hormone receptor action. The Journal of Steroid Biochemistry and Molecular Biology. 76: 31-42. PMID 11384861 DOI: 10.1016/S0960-0760(01)00052-8  0.413
2001 Wagner RL, Huber BR, Shiau AK, Kelly A, Cunha Lima ST, Scanlan TS, Apriletti JW, Baxter JD, West BL, Fletterick RJ. Hormone selectivity in thyroid hormone receptors. Molecular Endocrinology (Baltimore, Md.). 15: 398-410. PMID 11222741 DOI: 10.1210/Mend.15.3.0608  0.333
2001 Kinugawa K, Minobe WA, Wood WM, Ridgway EC, Baxter JD, Ribeiro RCJ, Tawadrous MF, Lowes BA, Long CS, Bristow MR. Signaling pathways responsible for fetal gene induction in the failing human heart: Evidence for altered thyroid hormone receptor gene expression Circulation. 103: 1089-1094. PMID 11222471 DOI: 10.1161/01.Cir.103.8.1089  0.407
2001 Ribeiro RC, Feng W, Wagner RL, Costa CH, Pereira AC, Apriletti JW, Fletterick RJ, Baxter JD. Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor. The Journal of Biological Chemistry. 276: 14987-95. PMID 11145963 DOI: 10.1074/Jbc.M010195200  0.429
2000 Schaufele F, Chang Cy, Liu W, Baxter JD, Nordeen SK, Wan Y, Day RN, McDonnell DP. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor Molecular Endocrinology. 14: 2024-2039. PMID 11117532 DOI: 10.1210/Mend.14.12.0572  0.364
2000 Webb P, Anderson CM, Valentine C, Nguyen P, Marimuthu A, West BL, Baxter JD, Kushner PJ. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs) Molecular Endocrinology. 14: 1976-1985. PMID 11117528 DOI: 10.1210/Mend.14.12.0566  0.439
2000 Trost SU, Swanson E, Gloss B, Wang-Iverson DB, Zhang H, Volodarsky T, Grover GJ, Baxter JD, Chiellini G, Scanlan TS, Dillmann WH. The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology. 141: 3057-64. PMID 10965874 DOI: 10.1210/Endo.141.9.7681  0.359
1999 An J, Ribeiro RCJ, Webb P, Gustafsson JA, Kushner PJ, Baxter JD, Leitman DC. Estradiol repression of tumor necrosis factor-α transcription requires estrogen receptor activation function-2 and is enhanced by coactivators Proceedings of the National Academy of Sciences of the United States of America. 96: 15161-15166. PMID 10611355 DOI: 10.1073/Pnas.96.26.15161  0.365
1999 Lopez GN, Webb P, Shinsako JH, Baxter JD, Greene GL, Kushner PJ. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators Molecular Endocrinology. 13: 897-909. PMID 10379889 DOI: 10.1210/Mend.13.6.0283  0.459
1999 Duncan KG, Jumper MD, Ribeiro RCJ, Bailey KR, Yen PM, Sugawara A, Patel A, Stern R, Chin WW, Baxter JD, Schwartz DM. Human trabecular meshwork cells as a thyroid hormone target tissue: Presence of functional thyroid hormone receptors Graefe's Archive For Clinical and Experimental Ophthalmology. 237: 231-240. PMID 10090587 DOI: 10.1007/S004170050224  0.39
1998 Apriletti JW, Ribeiro RC, Wagner RL, Feng W, Webb P, Kushner PJ, West BL, Nilsson S, Scanlan TS, Fletterick RJ, Baxter JD. Molecular and structural biology of thyroid hormone receptors. Clinical and Experimental Pharmacology & Physiology. Supplement. 25: S2-11. PMID 9809185 DOI: 10.1111/J.1440-1681.1998.Tb02293.X  0.463
1998 Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR. Structure and specificity of nuclear receptor-coactivator interactions. Genes & Development. 12: 3343-56. PMID 9808622 DOI: 10.1101/Gad.12.21.3343  0.596
1998 Ribeiro RC, Apriletti JW, Wagner RL, West BL, Feng W, Huber R, Kushner PJ, Nilsson S, Scanlan T, Fletterick RJ, Schaufele F, Baxter JD. Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studies. Recent Progress in Hormone Research. 53: 351-92; discussion 3. PMID 9769715  0.375
1998 Ribeiro RC, Apriletti JW, Wagner RL, Feng W, Kushner PJ, Nilsson S, Scanlan TS, West BL, Fletterick RJ, Baxter JD. X-ray crystallographic and functional studies of thyroid hormone receptor. The Journal of Steroid Biochemistry and Molecular Biology. 65: 133-41. PMID 9699866 DOI: 10.1016/S0960-0760(98)00029-6  0.42
1998 Chiellini G, Apriletti JW, Yoshihara HA, Baxter JD, Ribeiro RC, Scanlan TS. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chemistry & Biology. 5: 299-306. PMID 9653548 DOI: 10.1016/S1074-5521(98)90168-5  0.467
1998 Feng W, Ribeiro RC, Wagner RL, Nguyen H, Apriletti JW, Fletterick RJ, Baxter JD, Kushner PJ, West BL. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science (New York, N.Y.). 280: 1747-9. PMID 9624051 DOI: 10.1126/Science.280.5370.1747  0.38
1998 Zhang YH, Guo W, Wagner RL, Huang BL, McCabe L, Vilain E, Burris TP, Anyane-Yeboa K, Burghes AH, Chitayat D, Chudley AE, Genel M, Gertner JM, Klingensmith GJ, Levine SN, ... ... Baxter JD, et al. DAX1 mutations map to putative structural domains in a deduced three-dimensional model. American Journal of Human Genetics. 62: 855-64. PMID 9529340 DOI: 10.1086/301782  0.304
1997 Chuang FM, West BL, Baxter JD, Schaufele F. Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1/nuclear receptor transcriptional synergy Molecular Endocrinology. 11: 1332-1341. PMID 9259323 DOI: 10.1210/Mend.11.9.9978  0.451
1997 Saatcioglu F, Lopez G, West BL, Zandi E, Feng W, Lu H, Esmaili A, Apriletti JW, Kushner PJ, Baxter JD, Karin M. Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity. Molecular and Cellular Biology. 17: 4687-95. PMID 9234725 DOI: 10.1128/Mcb.17.8.4687  0.461
1996 Leitman DC, Costa CHRM, Graf H, Baxter JD, Ribeiro RCJ. Thyroid hormone activation of transcription is potentiated by activators of cAMP-dependent protein kinase Journal of Biological Chemistry. 271: 21950-21955. PMID 8703000 DOI: 10.1074/Jbc.271.36.21950  0.395
1996 Brechler V, Chu WN, Baxter JD, Thibault G, Reudelhuber TL. A protease processing site is essential for prorenin sorting to the regulated secretory pathway Journal of Biological Chemistry. 271: 20636-20640. PMID 8702811 DOI: 10.1074/Jbc.271.34.20636  0.337
1996 Chang W, Zhou W, Theill LE, Baxter JD, Schaufele F. An activation function in Pit-1 required selectively for synergistic transcription Journal of Biological Chemistry. 271: 17733-17738. PMID 8663468 DOI: 10.1074/Jbc.271.30.17733  0.39
1995 Sadovsky Y, Webb P, Lopez G, Baxter JD, Fitzpatrick PM, Gizang-Ginsberg E, Cavailles V, Parker MG, Kushner PJ. Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Molecular and Cellular Biology. 15: 1554-63. PMID 7862148 DOI: 10.1128/Mcb.15.3.1554  0.358
1995 Apriletti JW, Baxter JD, Lau KH, West BL. Expression of the rat alpha 1 thyroid hormone receptor ligand binding domain in Escherichia coli and the use of a ligand-induced conformation change as a method for its purification to homogeneity. Protein Expression and Purification. 6: 363-70. PMID 7663174 DOI: 10.1006/prep.1995.1048  0.341
1995 Ribeiro RC, Apriletti JW, West BL, Wagner RL, Fletterick RJ, Schaufele F, Baxter JD. The molecular biology of thyroid hormone action. Annals of the New York Academy of Sciences. 758: 366-89. PMID 7625705 DOI: 10.1111/J.1749-6632.1995.Tb24843.X  0.341
1995 Ribeiro RCJ, Kushner PJ, Baxter JD. The nuclear hormone receptor gene superfamily Annual Review of Medicine. 46: 443-453. PMID 7598477 DOI: 10.1146/annurev.med.46.1.443  0.388
1995 Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ. A structural role for hormone in the thyroid hormone receptor. Nature. 378: 690-7. PMID 7501015 DOI: 10.1038/378690A0  0.469
1994 McGrath ME, Wagner RL, Apriletti JW, West BL, Ramalingam V, Baxter JD, Fletterick RJ. Preliminary crystallographic studies of the ligand-binding domain of the thyroid hormone receptor complexed with triiodothyronine. Journal of Molecular Biology. 237: 236-9. PMID 8126736 DOI: 10.1006/Jmbi.1994.1224  0.389
1994 Kushner PJ, Baxter JD, Duncan KG, Lopez GN, Schaufele F, Uht RM, Webb P, West BL. Eukaryotic regulatory elements lurking in plasmid DNA: The activator protein-1 site in pUC Molecular Endocrinology. 8: 405-407. PMID 8052261 DOI: 10.1210/Mend.8.4.8052261  0.419
1994 Ribeiro RC, Apriletti JW, Yen PM, Chin WW, Baxter JD. Heterodimerization and deoxyribonucleic acid-binding properties of a retinoid X receptor-related factor. Endocrinology. 135: 2076-85. PMID 7956930 DOI: 10.1210/Endo.135.5.7956930  0.373
1993 Lopez G, Schaufele F, Webb P, Holloway JM, Baxter JD, Kushner PJ. Positive and negative modulation of jun action by thyroid hormone receptor at a unique AP1 site Molecular and Cellular Biology. 13: 3042-3049. PMID 8474460 DOI: 10.1128/Mcb.13.5.3042  0.483
1992 Baxter JD, Duncan K, Chu W, James MNG, Russell RB, Haidar MA, DeNoto FM, Hsueh W, Reudelhuber TL. Molecular biology of human renin and its gene Recent Progress in Hormone Research. 47: 211-257. PMID 1745821 DOI: 10.1016/B978-0-12-571147-0.50011-1  0.375
1992 Schaufele F, West BL, Baxter JD. Synergistic activation of the rat growth hormone promoter by Pit-1 and the thyroid hormone receptor. Molecular Endocrinology (Baltimore, Md.). 6: 656-65. PMID 1584227 DOI: 10.1210/Mend.6.4.1584227  0.441
1992 Webb P, Lopez GN, Greene GL, Baxter JD, Kushner PJ. The limits of the cellular capacity to mediate an estrogen response. Molecular Endocrinology (Baltimore, Md.). 6: 157-67. PMID 1569962 DOI: 10.1210/Mend.6.2.1569962  0.407
1992 Leitman DC, Mackow ER, Williams T, Baxter JD, West BL. The Core Promoter Region of the Tumor Necrosis Factor α Gene Confers Phorbol Ester Responsiveness to Upstream Transcriptional Activators Molecular and Cellular Biology. 12: 1352-1356. PMID 1545816 DOI: 10.1128/Mcb.12.3.1352  0.332
1992 Ribeiro RCJ, Kushner PJ, Apriletti JW, West BL, Baxter JD. Thyroid hormone alters in vitro DNA binding of monomers and dimers of thyroid hormone receptors Molecular Endocrinology. 6: 1142-1152. PMID 1508227 DOI: 10.1210/Mend.6.7.1508227  0.432
1992 Martial JA, Hallewell RA, Baxter JD, Goodman HM. Human growth hormone: complementary DNA cloning and expression in bacteria. 1979. Biotechnology (Reading, Mass.). 24: 293-8. PMID 1422028  0.517
1991 Baxter JD. Advances in molecular biology. Potential impact on diagnosis and treatment of disorders of the thyroid. The Medical Clinics of North America. 75: 41-59. PMID 1987446 DOI: 10.1016/S0025-7125(16)30471-0  0.351
1990 Duncan KG, Haidar MA, Baxter JD, Reudelhuber TL. Regulation of human renin expression in chorion cell primary cultures Proceedings of the National Academy of Sciences of the United States of America. 87: 7588-7592. PMID 2217188 DOI: 10.1073/Pnas.87.19.7588  0.404
1990 Kushner PJ, Hort E, Shine J, Baxter JD, Greene GL. Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Molecular Endocrinology (Baltimore, Md.). 4: 1465-73. PMID 2178215 DOI: 10.1210/Mend-4-10-1465  0.306
1990 Chu WN, Baxter JD, Reudelhuber TL. A targeting sequence for dense secretory granules resides in the active renin protein moiety of human preprorenin Molecular Endocrinology. 4: 1905-1913. PMID 2082189 DOI: 10.1210/Mend-4-12-1905  0.358
1988 Carilli CT, Vigne JL, Wallace LC, Smith LM, Wong MA, Lewicki JA, Baxter JD. Characterization of recombinant human prorenin and renin. Hypertension (Dallas, Tex. : 1979). 11: 713-6. PMID 3292415 DOI: 10.1161/01.Hyp.11.6.713  0.32
1988 Gardner DG, Cathala G, Lan NY, David-Inouye Y, Baxter JD. Processing of the primary transcript for the rat growth hormone gene in vivo. Dna (Mary Ann Liebert, Inc.). 7: 537-44. PMID 3180994 DOI: 10.1089/dna.1.1988.7.537  0.325
1988 Slater EP, Cato AC, Karin M, Baxter JD, Beato M. Progesterone induction of metallothionein-IIA gene expression. Molecular Endocrinology (Baltimore, Md.). 2: 485-91. PMID 2843758 DOI: 10.1210/Mend-2-6-485  0.519
1988 Akerblom IE, Slater EP, Beato M, Baxter JD, Mellon PL. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science (New York, N.Y.). 241: 350-3. PMID 2838908 DOI: 10.1126/Science.2838908  0.353
1988 Mellon SH, Baxter JD, Gutierrez-Hartmann A. Cell-specific expression of transfected brain identifier repetitive DNAs. Nucleic Acids Research. 16: 3963-76. PMID 2453842 DOI: 10.1093/Nar/16.9.3963  0.368
1988 Nicoll CS, Steiny SS, King DS, Nishioka RS, Mayer GL, Eberhardt NL, Baxter JD, Yamanaka MK, Miller JA, Seilhamer JJ. The primary structure of coho salmon growth hormone and its cDNA. General and Comparative Endocrinology. 68: 387-99. PMID 2449377 DOI: 10.1016/0016-6480(87)90077-3  0.384
1987 West BL, Catanzaro DF, Mellon SH, Cattini PA, Baxter JD, Reudelhuber TL. Interaction of a tissue-specific factor with an essential rat growth hormone gene promoter element Molecular and Cellular Biology. 7: 1193-1197. PMID 3561414 DOI: 10.1128/Mcb.7.3.1193  0.378
1987 Isaacs RE, Gardner DG, Baxter JD. Insulin regulation of rat growth hormone gene expression. Endocrinology. 120: 2022-8. PMID 3552628 DOI: 10.1210/Endo-120-5-2022  0.328
1987 Isaacs RE, Findell PR, Mellon P, Wilson CB, Baxter JD. Hormonal regulation of expression of the endogenous and transfected human growth hormone gene Molecular Endocrinology (Baltimore, Md.). 1: 569-576. PMID 3153479 DOI: 10.1210/Mend-1-8-569  0.383
1987 Gertz BJ, Gardner DG, Baxter JD. Glucocorticoid control of rat growth hormone gene expression: effect on cytoplasmic messenger ribonucleic acid production and degradation. Molecular Endocrinology (Baltimore, Md.). 1: 933-41. PMID 3153471 DOI: 10.1210/Mend-1-12-933  0.339
1987 Gardner DG, Vlasuk GP, Baxter JD, Fiddes JC, Lewicki JA. Identification of atrial natriuretic factor gene transcripts in the central nervous system of the rat. Proceedings of the National Academy of Sciences of the United States of America. 84: 2175-9. PMID 2951736 DOI: 10.1073/Pnas.84.8.2175  0.359
1986 Deschepper CF, Mellon SH, Cumin F, Baxter JD, Ganong WF. Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proceedings of the National Academy of Sciences of the United States of America. 83: 7552-6. PMID 3532116 DOI: 10.1073/Pnas.83.19.7552  0.338
1986 Fritz LC, Arfsten AE, Dzau VJ, Atlas SA, Baxter JD, Fiddes JC, Shine J, Cofer CL, Kushner P, Ponte PA. Characterization of human prorenin expressed in mammalian cells from cloned cDNA. Proceedings of the National Academy of Sciences of the United States of America. 83: 4114-8. PMID 3520565 DOI: 10.1073/Pnas.83.12.4114  0.322
1986 Slater EP, Anderson T, Cattini P, Isaacs R, Birnbaum MJ, Gardner DG, Eberhardt NL, Baxter JD. Mechanisms of glucocorticoid hormone action. Advances in Experimental Medicine and Biology. 196: 67-80. PMID 3012984 DOI: 10.1007/978-1-4684-5101-6_5  0.621
1986 Gardner DG, Hane S, Trachewsky D, Schenk D, Baxter JD. Atrial natriuretic peptide mRNA is regulated by glucocorticoids in vivo. Biochemical and Biophysical Research Communications. 139: 1047-54. PMID 2945558 DOI: 10.1016/S0006-291X(86)80283-2  0.302
1986 Gardner DG, Deschepper CF, Ganong WF, Hane S, Fiddes J, Baxter JD, Lewicki J. Extra-atrial expression of the gene for atrial natriuretic factor. Proceedings of the National Academy of Sciences of the United States of America. 83: 6697-701. PMID 2428040 DOI: 10.1073/Pnas.83.18.6697  0.321
1986 Gutierrez-Hartmann A, Baxter JD. Stable accumulation of a rat truncated repeat transcript in Xenopus oocytes. Proceedings of the National Academy of Sciences of the United States of America. 83: 3106-10. PMID 2422646 DOI: 10.1073/Pnas.83.10.3106  0.398
1985 Slater EP, Rabenau O, Karin M, Baxter JD, Beato M. Glucocorticoid receptor binding and activation of a heterologous promoter by dexamethasone by the first intron of the human growth hormone gene. Molecular and Cellular Biology. 5: 2984-92. PMID 3018491 DOI: 10.1128/Mcb.5.11.2984  0.595
1985 Savouret JF, Eberhardt NL, Cathala G, Baxter JD. Interaction of triiodothyronine-receptor complexes with simian virus 40 minichromosomes in monkey kidney CV-1 cells. Endocrinology. 116: 1259-66. PMID 2578953 DOI: 10.1210/Endo-116-4-1259  0.493
1984 Karin M, Eberhardt NL, Mellon SH, Malich N, Richards RI, Slater EP, Barta A, Martial JA, Baxter JD, Cathala G. Expression and hormonal regulation of the rat growth hormone gene in transfected mouse L cells. Dna (Mary Ann Liebert, Inc.). 3: 147-55. PMID 6723496  0.614
1984 Weisz A, Baxter JD, Lan NC. Interaction of sodium molybdate with highly purified glucocorticoid receptor Journal of Steroid Biochemistry. 20: 289-293. PMID 6708515 DOI: 10.1016/0022-4731(84)90219-X  0.37
1984 Karin M, Haslinger A, Holtgreve H, Cathala G, Slater E, Baxter JD. Activation of a heterologous promoter in response to dexamethasone and cadmium by metallothionein gene 5'-flanking DNA. Cell. 36: 371-9. PMID 6692472 DOI: 10.1016/0092-8674(84)90230-7  0.487
1984 West BL, Babbitt PC, Mendez B, Baxter JD. Creatine kinase protein sequence encoded by a cDNA made from Torpedo californica electric organ mRNA. Proceedings of the National Academy of Sciences of the United States of America. 81: 7007-11. PMID 6594677 DOI: 10.1073/Pnas.81.22.7007  0.304
1984 Lan NC, Karin M, Nguyen T, Weisz A, Birnbaum MJ, Eberhardt NL, Baxter JD. Mechanisms of glucocorticoid hormone action. Journal of Steroid Biochemistry. 20: 77-88. PMID 6368989 DOI: 10.1016/0022-4731(84)90192-4  0.679
1984 Gutierrez-Hartmann A, Lieberburg I, Gardner D, Baxter JD, Cathala GG. Transcription of two classes of rat growth hormone gene-associated repetitive DNA: differences in activity and effects of tandem repeat structure. Nucleic Acids Research. 12: 7153-73. PMID 6091058 DOI: 10.1093/Nar/12.18.7153  0.372
1983 Cathala G, Savouret JF, Mendez B, West BL, Karin M, Martial JA, Baxter JD. A method for isolation of intact, translationally active ribonucleic acid. Dna (Mary Ann Liebert, Inc.). 2: 329-35. PMID 6198133  0.554
1982 Lan NC, Baxter JD. A radioreceptor assay for direct measurement of plasma free glucocorticoid activity Journal of Clinical Endocrinology and Metabolism. 55: 516-523. PMID 7096539 DOI: 10.1210/Jcem-55-3-516  0.389
1982 Schachter BS, Johnson LK, Baxter JD, Roberts JL. Differential regulation by glucocorticoids of proopiomelanocortin mRNA levels in the anterior and intermediate lobes of the rat pituitary Endocrinology. 110: 1442-1444. PMID 7060531 DOI: 10.1210/Endo-110-4-1442  0.349
1982 Barta A, Richards RI, Baxter JD, Shine J. Primary structure and evolution of rat growth hormone gene. Proceedings of the National Academy of Sciences of the United States of America. 78: 4867-71. PMID 6946433 DOI: 10.1073/Pnas.78.8.4867  0.389
1982 Wegnez M, Schachter BS, Baxter JD, Martial JA. Hormonal regulation of growth hormone mRNA. Dna (Mary Ann Liebert, Inc.). 1: 145-53. PMID 6897720  0.533
1982 Lan NC, Nguyen T, Cathala G, Wolff ME, Kollman PA, Wegnez M, Martial JA, Baxter JD. Molecular mechanisms of glucocorticoid hormone action. Journal of Molecular and Cellular Cardiology. 14: 43-8. PMID 6754955 DOI: 10.1016/0022-2828(82)90128-6  0.656
1982 David-Inouye Y, Somack R, Nordeen SK, Apriletti JW, Baxter JD, Eberhardt NL. Photoaffinity labelling of the rat liver nuclear thyroid hormone receptor with [125I]triiodothyronine. Endocrinology. 111: 1758-60. PMID 6290199 DOI: 10.1210/Endo-111-5-1758  0.322
1982 Cooke NE, Baxter JD. Structural analysis of the prolactin gene suggests a separate origin for its 5' end. Nature. 297: 603-6. PMID 6283362 DOI: 10.1038/297603A0  0.37
1982 Lan NC, Graham B, Bartter FC, Baxter JD. Binding of steroids to mineralocorticoid receptors: Implications for in vivo occupancy by glucocorticoids Journal of Clinical Endocrinology and Metabolism. 54: 332-342. PMID 6274900 DOI: 10.1210/Jcem-54-2-332  0.38
1981 Seleznev YM, Shnyra AA, Volkova NG, Smirnov VN, Djozdjevic-Markovic R, Lan N, Baxter JD. Chromatographic studies on interconversions of "non-activated" and "activated" forms of glucocorticoid-receptor complexes from rat heart cytosol. Journal of Steroid Biochemistry. 15: 55-61. PMID 7339276 DOI: 10.1016/0022-4731(81)90258-2  0.383
1981 Charles MA, Martial J, Zolock D, Morrissey R, Baxter JD. Regulation of calcium-binding protein messenger RNA by 1,25-dihydroxycholecalciferol. Calcified Tissue International. 33: 15-8. PMID 6780152 DOI: 10.1007/Bf02409407  0.332
1981 Miller WL, Coit D, Baxter JD, Martial JA. Cloning of bovine prolactin cDNA and evolutionary implications of its sequence. Dna (Mary Ann Liebert, Inc.). 1: 37-50. PMID 6299665  0.542
1981 Lan NC, Matulich DT, Morris JA, Baxter JD. Mineralocorticoid receptor-like aldosterone-binding protein in cell culture Endocrinology. 109: 1963-1970. PMID 6273124 DOI: 10.1210/Endo-109-6-1963  0.475
1981 Cooke NE, Coit D, Shine J, Baxter JD, Martial JA. Human prolactin. cDNA structural analysis and evolutionary comparisons. The Journal of Biological Chemistry. 256: 4007-16. PMID 6260780  0.537
1981 Miller WL, Baxter JD, Martial JA. Evolution of the genes for growth hormone (GH) and Prolactin (Prl) Pediatric Research. 15: 1550-1550. DOI: 10.1203/00006450-198112000-00093  0.53
1981 Miller WL, Baxter JD. Synthesis of biologically active proteins by recombinant DNA technology Drug Development Research. 1: 435-454. DOI: 10.1002/Ddr.430010409  0.319
1980 Bloom E, Matulich DT, Lan NC, Higgins SJ, Simons SS, Baxter JD. Nuclear binding of glucocorticoid receptors: Relations between cytosol binding, activation and the biological response Journal of Steroid Biochemistry. 12: 175-184. PMID 7421206 DOI: 10.1016/0022-4731(80)90267-8  0.46
1980 Mendez B, Valenzuela P, Martial JA, Baxter JD. Cell-free synthesis of acetylcholine receptor polypeptides. Science (New York, N.Y.). 209: 695-7. PMID 7394526 DOI: 10.1126/Science.7394526  0.591
1980 Owerbach D, Rutter WJ, Martial JA, Baxter JD, Shows TB. Genes for growth hormone, chorionic somatommammotropin, and growth hormones-like gene on chromosome 17 in humans. Science (New York, N.Y.). 209: 289-92. PMID 7384802 DOI: 10.1126/Science.7384802  0.517
1980 Cooke NE, Coit D, Weiner RI, Baxter JD, Martial JA. Structure of cloned DNA complementary to rat prolactin messenger RNA. The Journal of Biological Chemistry. 255: 6502-10. PMID 6993473  0.481
1980 Johnson LK, Vlodavsky I, Baxter JD, Gospodarowicz D. Nuclear accumulation of epidermal growth factor in cultured rat pituitary cells Nature. 287: 340-343. PMID 6968406 DOI: 10.1038/287340A0  0.381
1980 Miller WL, Martial JA, Baxter JD. Molecular cloning of DNA complementary to bovine growth hormone mRNA. The Journal of Biological Chemistry. 255: 7521-4. PMID 6893197  0.536
1980 Miller WL, Johnson LK, Baxter JD, Roberts JL. Processing of the precursor to corticotropin and β-lipotropin in humans Proceedings of the National Academy of Sciences of the United States of America. 77: 5211-5215. PMID 6254067 DOI: 10.1073/Pnas.77.9.5211  0.325
1980 Johnson LK, Baxter JD, Vlodavsky I, Gospodarowicz D. Epidermal growth factor and expression of specific genes: Effects on cultured rat pituitary cells are dissociable from the mitogenic response Proceedings of the National Academy of Sciences of the United States of America. 77: 394-398. PMID 6244557 DOI: 10.1073/Pnas.77.1.394  0.445
1979 Martial JA, Seeburg PH, Matulich DT, Goodman HM, Baxter JD. Regulation of growth hormone messenger RNA. Monographs On Endocrinology. 12: 279-89. PMID 492172  0.561
1979 Cheng S, Eberhardt NL, Robbins J, Baxter JD, Pastan I. Fluorescent rhodamine-labeled thyroid hormone derivatives: synthesis and binding to the thyroid hormone nuclear receptor. Febs Letters. 100: 113-6. PMID 437091 DOI: 10.1016/0014-5793(79)81143-6  0.428
1979 Harris AW, Baxter JD. Variations in cellular sensitivity to glucocorticoids: observations and mechanisms. Monographs On Endocrinology. 12: 423-48. PMID 386087 DOI: 10.1007/978-3-642-81265-1_23  0.335
1979 Baxter JD, Rousseau GG. Glucocorticoid hormone action: an overview. Monographs On Endocrinology. 12: 1-24. PMID 386083 DOI: 10.1007/978-3-642-81265-1_1  0.331
1979 Martial JA, Hallewell RA, Baxter JD, Goodman HM. Human growth hormone: complementary DNA cloning and expression in bacteria. Science (New York, N.Y.). 205: 602-7. PMID 377496 DOI: 10.1126/Science.377496  0.55
1979 Baxter JD. Mechanisms of glucocorticoid inhibition of growth. Kidney International. 14: 330-3. PMID 366226 DOI: 10.1038/Ki.1978.132  0.382
1979 Baxter JD, Eberhardt NL, Apriletti JW, Johnson LK, Ivarie RD, Schachter BS, Morris JA, Seeburg PH, Goodman HM, Latham KR, Polansky JR, Martial JA. Thyroid hormone receptors and responses. Recent Progress in Hormone Research. 35: 97-153. PMID 229530 DOI: 10.1016/B978-0-12-571135-7.50007-2  0.653
1979 Eberhardt NL, Ring JC, Johnson LK, Latham KR, Apriletti JW, Kitsis RN, Baxter JD. Regulation of activity of chromatin receptors for thyroid hormone: Possible involvement of histone-like proteins Proceedings of the National Academy of Sciences of the United States of America. 76: 5005-5009. PMID 228271 DOI: 10.1073/Pnas.76.10.5005  0.322
1979 Higgins SJ, Baxter JD, Rousseau GG. Nuclear binding of glucocorticoid receptors. Monographs On Endocrinology. 12: 135-60. PMID 40113 DOI: 10.1007/978-3-642-81265-1_8  0.313
1978 Seeburg PH, Shine J, Martial JA, Ivarie RD, Morris JA, Ullrich A, Baxter JD, Goodman HM. Synthesis of growth hormone by bacteria. Nature. 276: 795-8. PMID 364320 DOI: 10.1038/276795A0  0.574
1977 Matulich DT, Spindler BJ, Schambelan M, Baxter JD. Mineralocorticoid receptors in human kidney. The Journal of Clinical Endocrinology and Metabolism. 43: 1170-4. PMID 993320 DOI: 10.1210/Jcem-43-5-1170  0.422
1977 Seeburg PH, Shine J, Martial JA, Ullrich A, Goodman HM, Baxter JD. Nucleotide sequence of a human gene coding for a polypeptide hormone. Transactions of the Association of American Physicians. 90: 109-16. PMID 611657  0.517
1977 Shine J, Seeburg PH, Martial JA, Baxter JD, Goodman HM. Construction and analysis of recombinant DNA for human chorionic somatomammotropin. Nature. 270: 494-9. PMID 593368 DOI: 10.1038/270494A0  0.562
1977 Seeburg PH, Shine J, Martial JA, Baxter JD, Goodman HM. Nucleotide sequence and amplification in bacteria of structural gene for rat growth hormone. Nature. 270: 486-94. PMID 339105 DOI: 10.1038/270486A0  0.6
1977 Martial JA, Seeburg PH, Guenzi D, Goodman HM, Baxter JD. Regulation of growth hormone gene expression: synergistic effects of thyroid and glucocorticoid hormones. Proceedings of the National Academy of Sciences of the United States of America. 74: 4293-5. PMID 270674 DOI: 10.1073/Pnas.74.10.4293  0.558
1977 Martial JA, Baxter JD, Goodman HM, Seeburg PH. Regulation of growth hormone messenger RNA by thyroid and glucocorticoid hormones. Proceedings of the National Academy of Sciences of the United States of America. 74: 1816-20. PMID 266704 DOI: 10.1073/Pnas.74.5.1816  0.56
1977 Papavasiliou SS, Martial JA, Latham KR, Baxter JD. Thyroid hormonelike actions of 3,3',5'-L-triiodothyronine nad 3,3'-diiodothyronine. The Journal of Clinical Investigation. 60: 1230-9. PMID 199617 DOI: 10.1172/Jci108882  0.535
1977 Seeburg PH, Shine J, Martial JA, Ullrich A, Baxter JD, Goodman HM. Nucleotide sequence of part of the gene for human chorionic somatomammotropin: purification of DNA complementary to predominant mRNA species. Cell. 12: 157-65. PMID 71212 DOI: 10.1016/0092-8674(77)90193-3  0.565
1976 Baxter JD. Glucocorticoid hormone action Pharmacology and Therapeutics: Part B: General and Systematic. 2: 605-659. PMID 790403 DOI: 10.1016/0306-039X(76)90010-6  0.417
1976 Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Taylor AA, Bartter FC. Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states. The Journal of Clinical Investigation. 58: 579-89. PMID 182723 DOI: 10.1172/Jci108504  0.361
1976 Levy B, Baxter JD. Distribution of thyroid and glucocorticoid hormone receptors in transcriptionally active and inactive chromatin. Biochemical and Biophysical Research Communications. 68: 1045-51. PMID 178301 DOI: 10.1016/0006-291X(76)90301-6  0.43
1976 Simons SS, Martinez HM, Garcea RL, Baxter JD, Tomkins GM. Interaction of glucocorticoid receptor-steroid complexes with acceptor sites. The Journal of Biological Chemistry. 251: 334-43. PMID 173716  0.588
1975 Ballard PL, Carter JP, Graham BS, Baxter JD. A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man Journal of Clinical Endocrinology and Metabolism. 41: 290-304. PMID 169279 DOI: 10.1210/Jcem-41-2-290  0.329
1975 Charles MA, Ryffel GU, Obinata M, McCarthy BJ, Baxter JD. Nuclear receptors for thyroid hormone: evidence for nonrandom distribution within chromatin. Proceedings of the National Academy of Sciences of the United States of America. 72: 1787-91. PMID 168576 DOI: 10.1073/pnas.72.5.1787  0.327
1975 Rousseau GG, Higgins SJ, Baxter JD, Gelfand D, Tomkins GM. Binding of glucocorticoid receptors to DNA. The Journal of Biological Chemistry. 250: 6015-21. PMID 168206  0.584
1975 MacLeod KM, Baxter JD. DNA binding of thyroid hormone receptors Biochemical and Biophysical Research Communications. 62: 577-583. PMID 164184 DOI: 10.1016/0006-291X(75)90437-4  0.358
1974 Ballard PL, Baxter JD, Higgins SJ, Rousseau GG, Tomkins GM. General presence of glucocorticoid receptors in mammalian tissues. Endocrinology. 94: 998-1002. PMID 4362047 DOI: 10.1210/Endo-94-4-998  0.616
1974 Rousseau GG, Higgins SJ, Baxter JD, Tomkins GM. Nuclear acceptor sites for glucocorticoid receptors Journal of Steroid Biochemistry. 5: 935-939. DOI: 10.1016/0022-4731(74)90088-0  0.659
1973 Higgins SJ, Rousseau GG, Baxter JD, Tomkins GM. Nuclear binding of steroid receptors: comparison in intact cells and cell-free systems. Proceedings of the National Academy of Sciences of the United States of America. 70: 3415-8. PMID 4357870 DOI: 10.1073/Pnas.70.12.3415  0.597
1973 Higgins SJ, Rousseau GG, Baxter JD, Tomkins GM. Nature of nuclear acceptor sites for glucocorticoid- and estrogen-receptor complexes. The Journal of Biological Chemistry. 248: 5873-9. PMID 4353280  0.564
1973 Higgins SJ, Rousseau GG, Baxter JD, Tomkins GM. Early events in glucocorticoid action. Activation of the steroid receptor and its subsequent specific nuclear binding studied in a cell-free system. The Journal of Biological Chemistry. 248: 5866-72. PMID 4353279  0.596
1973 Santi DV, Sibley CH, Perriard ER, Tomkins GM, Baxter JD. A filter assay for steroid hormone receptors. Biochemistry. 12: 2412-6. PMID 4350952 DOI: 10.1021/Bi00737A007  0.674
1973 Rousseau GG, Baxter JD, Higgins SJ, Tomkins GM. Steroid-induced nuclear binding of glucocorticoid receptors in intact hepatoma cells. Journal of Molecular Biology. 79: 539-54. PMID 4148423 DOI: 10.1016/0022-2836(73)90405-1  0.672
1972 Rosenau W, Baxter JD, Rousseau GG, Tomkins GM. Mechanism of resistance to steroids: glucocorticoid receptor defect in lymphoma cells. Nature: New Biology. 237: 20-4. PMID 4503684 DOI: 10.1038/Newbio237020A0  0.571
1972 Tomkins GM, Levinson BB, Baxter JD, Dethlefsen L. Further evidence for posttranscriptional control of inducible tyrosine aminotransferase synthesis in cultured hepatoma cells. Nature: New Biology. 239: 9-14. PMID 4404031 DOI: 10.1038/Newbio239009A0  0.527
1972 Baxter JD, Rousseau GG, Benson MC, Garcea RL, Ito J, Tomkins GM. Role of DNA and specific cytoplasmic receptors in glucocorticoid action. Proceedings of the National Academy of Sciences of the United States of America. 69: 1892-6. PMID 4403081 DOI: 10.1073/Pnas.69.7.1892  0.656
1972 Rousseau GG, Baxter JD, Tomkins GM. Glucocorticoid receptors: relations between steroid binding and biological effects. Journal of Molecular Biology. 67: 99-115. PMID 4402888 DOI: 10.1016/0022-2836(72)90389-0  0.638
1972 Rousseau G, Baxter JD, Funder JW, Edelman IS, Tomkins GM. Glucocorticoid and mineralocorticoid receptors for aldosterone. Journal of Steroid Biochemistry. 3: 219-27. PMID 4346760 DOI: 10.1016/0022-4731(72)90053-2  0.6
1972 Levinson BB, Baxter JD, Rousseau GG, Tomkins GM. Cellular site of glucocorticoid-receptor complex formation. Science (New York, N.Y.). 175: 189-90. PMID 4332760 DOI: 10.1126/Science.175.4018.189  0.631
1971 Baxter JD, Tomkins GM. Specific cytoplasmic glucocorticoid hormone receptors in hepatoma tissue culture cells. Proceedings of the National Academy of Sciences of the United States of America. 68: 932-7. PMID 4396919 DOI: 10.1073/Pnas.68.5.932  0.62
1971 Baxter JD, Harris AW, Tomkins GM, Cohn M. Glucocorticoid receptors in lymphoma cells in culture: relationship to glucocorticoid killing activity. Science (New York, N.Y.). 171: 189-91. PMID 4395230 DOI: 10.1126/Science.171.3967.189  0.598
1970 Baxter JD, Tomkins GM. The relationship between glucocorticoid binding and tyrosine aminotransferase induction in hepatoma tissue culture cells. Proceedings of the National Academy of Sciences of the United States of America. 65: 709-15. PMID 4315614 DOI: 10.1073/Pnas.65.3.709  0.622
1970 Tomkins GM, Martin DW, Stellwagen RH, Baxter JD, Mamont P, Levinson BB. Regulation of Specific Protein Synthesis in Eucaryotic Cells Cold Spring Harbor Symposia On Quantitative Biology. 35: 635-640. DOI: 10.1101/Sqb.1970.035.01.078  0.5
Low-probability matches (unlikely to be authored by this person)
2008 Bryzgalova G, Effendic S, Khan A, Rehnmark S, Barbounis P, Boulet J, Dong G, Singh R, Shapses S, Malm J, Webb P, Baxter JD, Grover GJ. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141. The Journal of Steroid Biochemistry and Molecular Biology. 111: 262-7. PMID 18621127 DOI: 10.1016/J.Jsbmb.2008.06.010  0.299
2003 Yoshihara HA, Apriletti JW, Baxter JD, Scanlan TS. Structural determinants of selective thyromimetics. Journal of Medicinal Chemistry. 46: 3152-61. PMID 12825953 DOI: 10.1021/Jm0301181  0.298
1987 Catanzaro DF, West BL, Baxter JD, Reudelhuber TL. A pituitary-specific factor interacts with an upstream promotor element in the rat growth hormone gene Molecular Endocrinology (Baltimore, Md.). 1: 90-96. PMID 3454872 DOI: 10.1210/mend-1-1-90  0.297
1988 Baxter JD, Lewicki JA, Gardner DG. Atrial Natriuretic Peptide Nature Biotechnology. 6: 529-546. DOI: 10.1038/Nbt0588-529  0.297
1992 Chu WN, Mercure C, Baxter JD, Reudelhuber TL. Molecular determinants of human prorenin processing Hypertension. 20: 782-787. PMID 1452293 DOI: 10.1161/01.Hyp.20.6.782  0.297
1999 Cavalieri RR, Simeoni LA, Park SW, Baxter JD, Scharschmidt BF, Ribeiro RCJ, Lomri N. Thyroid hormone export in rat FRTL-5 thyroid cells and mouse NIH-3T3 cells is carrier-mediated, verapamil-sensitive, and stereospecific Endocrinology. 140: 4948-4954. PMID 10537118 DOI: 10.1210/Endo.140.11.7127  0.295
2003 Huber BR, Desclozeaux M, West BL, Cunha-Lima ST, Nguyen HT, Baxter JD, Ingraham HA, Fletterick RJ. Thyroid hormone receptor-beta mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the N-terminal ligand-binding domain. Molecular Endocrinology (Baltimore, Md.). 17: 107-16. PMID 12511610 DOI: 10.1210/Me.2002-0097  0.295
2002 Neves FA, Cavalieri RR, Simeoni LA, Gardner DG, Baxter JD, Scharschmidt BF, Lomri N, Ribeiro RC. Thyroid hormone export varies among primary cells and appears to differ from hormone uptake. Endocrinology. 143: 476-83. PMID 11796501 DOI: 10.1210/Endo.143.2.8631  0.294
2005 Meng X, Webb P, Yang YF, Shuen M, Yousef AF, Baxter JD, Mymryk JS, Walfish PG. E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode Proceedings of the National Academy of Sciences of the United States of America. 102: 6267-6272. PMID 15849266 DOI: 10.1073/pnas.0501491102  0.292
1980 Baxter JD. Recombinant DNA and medical progress. Hospital Practice. 15: 57-67. PMID 6250971 DOI: 10.1080/21548331.1980.11946554  0.292
1986 Babbitt PC, Kenyon GL, Kuntz ID, Cohen FE, Baxter JD, Benfield PA, Buskin JD, Gilbert WA, Hauschka SD, Hossle JP, Ordahl CP, Pearson ML, Perriard JC, Pickering LA, Putney SD, et al. Comparisons of creatine kinase primary structures Journal of Protein Chemistry. 5: 1-14. DOI: 10.1007/Bf01025580  0.288
1994 Yen PM, Brubaker JH, Apriletti JW, Baxter JD, Chin WW. Roles of 3,5,3′-Triiodothyronine and Deoxyribonucleic Acid Binding on Thyroid Hormone Receptor Complex Formation Endocrinology. 134: 1075-1081. PMID 8119145 DOI: 10.1210/Endo.134.3.8119145  0.286
1979 Roberts JL, Budarf ML, Baxter JD, Herbert E. Selective reduction of proadrenocorticotropin/endorphin proteins and messenger ribonucleic acid activity in mouse pituitary tumor cells by glucocorticoids. Biochemistry. 18: 4907-15. PMID 228704 DOI: 10.1021/Bi00589A019  0.285
1996 Neves FAR, Duncan KG, Baxter JD. Cathepsin B is a prorenin processing enzyme Hypertension. 27: 514-517. PMID 8613195 DOI: 10.1161/01.Hyp.27.3.514  0.285
1992 Baxter JD. The effects of glucocorticoid therapy. Hospital Practice (Office Ed.). 27: 111-4, 115-8, 123 pa. PMID 1522153 DOI: 10.1080/21548331.1992.11705486  0.285
1986 Hsueh WA, Do YS, Shinagawa T, Tam H, Ponte PA, Baxter JD, Shine J, Fritz LC. Biochemical similarity of expressed human prorenin and native inactive renin. Hypertension (Dallas, Tex. : 1979). 8: II78-83. PMID 3522420 DOI: 10.1161/01.Hyp.8.6_Pt_2.Ii78  0.283
2004 Rodrigues MC, Santos GM, da Silva CA, Baxter JD, Webb P, Lomri N, Neves FA, Ribeiro RC, Simeoni LA. Thyroid hormone transport is disturbed in erythrocytes from patients with chronic renal failure on hemodialysis. Renal Failure. 26: 461-6. PMID 15462116 DOI: 10.1081/Jdi-200026760  0.282
1987 Metzler CH, Gardner DG, Keil LC, Baxter JD, Ramsay DJ. Increased synthesis and release of atrial peptide during DOCA escape in conscious dogs. The American Journal of Physiology. 252: R188-92. PMID 2949629 DOI: 10.1152/Ajpregu.1987.252.1.R188  0.281
2011 Deng T, Sieglaff DH, Zhang A, Lyon CJ, Ayers SD, Cvoro A, Gupte AA, Xia X, Baxter JD, Webb P, Hsueh WA. A peroxisome proliferator-activated receptor γ (PPARγ)/ PPARγ coactivator 1β autoregulatory loop in adipocyte mitochondrial function Journal of Biological Chemistry. 286: 30723-30731. PMID 21719705 DOI: 10.1074/Jbc.M111.251926  0.281
2013 Vatner DF, Weismann D, Beddow SA, Kumashiro N, Erion DM, Liao XH, Grover GJ, Webb P, Phillips KJ, Weiss RE, Bogan JS, Baxter J, Shulman GI, Samuel VT. Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways. American Journal of Physiology. Endocrinology and Metabolism. 305: E89-100. PMID 23651850 DOI: 10.1152/Ajpendo.00573.2012  0.28
1992 Gardner DG, Camargo MJF, Behringer RR, Brinster RL, Baxter JD, Atlas SA, Laragh JH, Deschepper CF. Atrial natriuretic peptide synthesis in atrial tumors of transgenic mice American Journal of Physiology - Endocrinology and Metabolism. 262. PMID 1373564 DOI: 10.1152/Ajpendo.1992.262.4.E524  0.276
1987 Gardner DG, Deschepper CF, Baxter JD. The gene for the atrial natriuretic factor is expressed in the aortic arch Hypertension. 9: 103-106. PMID 2947852 DOI: 10.1161/01.Hyp.9.1.103  0.273
1983 Johnson LK, Longenecker JP, Baxter JD, Dallman MF, Widmaier EP, Eberhardt NL. Glucocorticoid action: a mechanism involving nuclear and non-nuclear pathways. The British Journal of Dermatology. 6-23. PMID 6291571 DOI: 10.1111/J.1365-2133.1982.Tb01026.X  0.27
1980 Shine J, Fettes I, Lan NC, Roberts JL, Baxter JD. Expression of cloned beta-endorphin gene sequences by Escherichia coli. Nature. 285: 456-63. PMID 6250034 DOI: 10.1038/285456A0  0.267
1978 Wolff ME, Baxter JD, Kollman PA, Lee DL, Kuntz ID, Bloom E, Matulich DT, Morris J. Nature of steroid-glucocorticoid receptor interactions: thermodynamic analysis of the binding reaction. Biochemistry. 17: 3201-8. PMID 567487 DOI: 10.1021/Bi00609A005  0.266
1988 Masharani U, Baxter JD, Frossard PM. Two EcoT14I RFLPs at the human renin (REN) gene locus. Nucleic Acids Research. 16: 6253. PMID 2899876 DOI: 10.1093/Nar/16.13.6253  0.265
2002 Marimuthu A, Feng W, Tagami T, Nguyen H, Jameson JL, Fletterick RJ, Baxter JD, West BL. TR surfaces and conformations required to bind nuclear receptor corepressor. Molecular Endocrinology (Baltimore, Md.). 16: 271-86. PMID 11818500 DOI: 10.1210/Mend.16.2.0777  0.261
1984 Kimura N, Kimura N, Cathala G, Baxter JD, Johnson GS. Nicotinamide and its derivatives increase growth hormone and prolactin synthesis in cultured GH3 cells: role for ADP-ribosylation in modulating specific gene expression. Dna (Mary Ann Liebert, Inc.). 2: 195-203. PMID 6227466 DOI: 10.1089/dna.1983.2.195  0.253
2002 Chiellini G, Nguyen NH, Apriletti JW, Baxter JD, Scanlan TS. Synthesis and biological activity of novel thyroid hormone analogues: 5'-aryl substituted GC-1 derivatives. Bioorganic & Medicinal Chemistry. 10: 333-46. PMID 11741782 DOI: 10.1016/S0968-0896(01)00284-X  0.251
1987 Cattini PA, Peritz LN, Anderson TR, Baxter JD, Eberhardt NL. The 5'-flanking sequences of the human growth hormone gene contain a cell-specific control element. Dna (Mary Ann Liebert, Inc.). 5: 503-9. PMID 3469066 DOI: 10.1089/dna.1.1986.5.503  0.244
2000 Trost SU, Swanson E, Gloss B, Wang-Iverson DB, Zhang H, Volodarsky T, Grover GJ, Baxter JD, Chiellini G, Scanlan TS, Dillmann WH. The Thyroid Hormone Receptor-β-Selective Agonist GC-1 Differentially Affects Plasma Lipids and Cardiac Activity. Endocrinology. 141: 3057-3064. PMID 28204388 DOI: 10.1210/endo.141.9.7681  0.237
1990 Lenz T, Sealey JE, Lappe RW, Carilli C, Oshiro GT, Baxter JD, Laragh JH. Infusion of recombinant human prorenin into rhesus monkeys. Effects on hemodynamics, renin-angiotensin-aldosterone axis and plasma testosterone. American Journal of Hypertension. 3: 257-61. PMID 2189442 DOI: 10.1093/Ajh/3.4.257  0.237
1979 Johnson LK, Baxter JD, Rousseau GG. Mechanisms of glucocorticoid receptor function Monographs On Endocrinology. 12: 305-326. PMID 226871 DOI: 10.1007/978-3-642-81265-1_17  0.233
1999 Cavalieri RR, Simeoni LA, Park SW, Baxter JD, Scharschmidt BF, Ribeiro RC, Lomri N. Thyroid Hormone Export in Rat FRTL-5 Thyroid Cells and Mouse NIH-3T3 Cells Is Carrier-Mediated, Verapamil-Sensitive, and Stereospecific1. Endocrinology. 140: 4948-4954. PMID 28200715 DOI: 10.1210/endo.140.11.7127  0.232
2003 Baxter JD, Young WF, Webb P. Cardiovascular endocrinology: introduction. Endocrine Reviews. 24: 253-60. PMID 12788796 DOI: 10.1210/Er.2003-0099  0.23
1975 Baxter JD, Higgins SJ, Rousseau GG. Measurement of specific binding of a ligand in intact cells: dexamethasone binding by cultured hepatoma cells. Methods in Enzymology. 36: 240-8. PMID 162981 DOI: 10.1016/S0076-6879(75)36023-0  0.226
1979 Fiddes JC, Seeburg PH, DeNoto FM, Hallewell RA, Baxter JD, Goodman HM. Structure of genes for human growth hormone and chorionic somatomammotropin. Proceedings of the National Academy of Sciences of the United States of America. 76: 4294-8. PMID 291965 DOI: 10.1073/Pnas.76.9.4294  0.226
1977 Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Bartter FC. Role of steroids in hypertension: evaluation of plasma mineralocorticoid activity with aldosterone receptors. Clinical Science and Molecular Medicine. Supplement. 3: 321s-324s. PMID 1071637 DOI: 10.1042/cs051321s  0.226
1999 Duncan KG, Bailey KR, Baxter JD, Schwartz DM. The human fetal retinal pigment epithelium: A target tissue for thyroid hormones Ophthalmic Research. 31: 399-406. PMID 10474068 DOI: 10.1159/000055564  0.223
1975 Baxter JD, Santi DV, Rousseau GG. A filter technique for measurement of steroid-receptor binding. Methods in Enzymology. 36: 234-9. PMID 162980 DOI: 10.1016/S0076-6879(75)36022-9  0.216
1985 Hardman JA, Hort YJ, Catanzaro DF, Tellam JT, Baxter JD, Morris BJ, Shine J. Primary structure of the human renin gene. Dna (Mary Ann Liebert, Inc.). 3: 457-68. PMID 6391881 DOI: 10.1089/dna.1.1984.3.457  0.208
1994 Williard R, Benz CC, Baxter JD, Kushner P, Hunt CA. Paradoxical production of target protein using antisense RNA expression vectors. Gene. 149: 21-4. PMID 7958984 DOI: 10.1016/0378-1119(94)90407-3  0.207
1991 Hsueh WA, Baxter JD. Human prorenin. Hypertension (Dallas, Tex. : 1979). 17: 469-77. PMID 2013474 DOI: 10.1161/01.hyp.17.4.469  0.206
2010 Ladenson PW, Kristensen JD, Ridgway EC, Olsson AG, Carlsson B, Klein I, Baxter JD, Angelin B. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia Obstetrical and Gynecological Survey. 65: 512-513. DOI: 10.1097/OGX.0b013e3181f07bed  0.206
1988 BAXTER JD. Control of growth hormone gene expression Biochemical Society Transactions. 16: 694-694. DOI: 10.1042/bst0160694  0.2
1987 Gutierrez-Hartmann A, Baxter JD. Differential ability of various plasmid DNAs to sequester inhibitors of RNA polymerase III transcription. Dna (Mary Ann Liebert, Inc.). 6: 231-7. PMID 3109865 DOI: 10.1089/dna.1987.6.231  0.199
2004 Angelin B, Baxter J, Bergström G, Bigiani A, Blundell J, Buck L, Bufe B, Drevon C, Döving K, Garza C, Hall G, Hanson LA, Hernell O, Hill D, James P, et al. Taste and smell: From molecular biology to behaviour Nutrition Reviews. 62: S224-S241. DOI: 10.1111/J.1753-4887.2004.Tb00103.X  0.191
2008 Berkenstam A, Kristensen J, Mellström K, Carlsson B, Malm J, Rehnmark S, Garg N, Andersson CM, Rudling M, Sjöberg F, Angelin B, Baxter JD. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans Proceedings of the National Academy of Sciences of the United States of America. 105: 663-667. PMID 18160532 DOI: 10.1073/pnas.0705286104  0.185
1996 Ribeiro RCJ, Cavalieri RR, Lomri N, Rahmaoui CM, Baxter JD, Scharschmidt BF. Thyroid hormone export regulates cellular hormone content and response Journal of Biological Chemistry. 271: 17147-17151. PMID 8663353 DOI: 10.1074/jbc.271.29.17147  0.181
1986 SLATER EP, BAXTER JD, EBERHARDT NL. Evolution of the Growth Hormone Gene Family American Zoologist. 26: 939-949. DOI: 10.1093/icb/26.4.939  0.176
1982 Nordeen SK, Mason AJ, Richards RI, Baxter JD, Shine J. Mouse kallikrein arginyl-esteropeptidase genes: Analysis of cloned cDNAs suggests rapid functional divergence from a common ancestral sequence Dna. 1: 309-311. PMID 6926406 DOI: 10.1089/dna.1.1982.1.309  0.169
1992 Shinagawa T, Do YS, Baxter J, Hsueh WA. Purification and characterization of human truncated prorenin. Biochemistry. 31: 2758-64. PMID 1547216 DOI: 10.1021/bi00125a016  0.167
1979 Roberts JL, Seeburg PH, Shine J, Herbert E, Baxter JD, Goodman HM. Corticotropin and beta-endorphin: construction and analysis of recombinant DNA complementary to mRNA for the common precursor. Proceedings of the National Academy of Sciences of the United States of America. 76: 2153-7. PMID 221916 DOI: 10.1073/Pnas.76.5.2153  0.163
2011 Cronin J, McAdam E, Danikas A, Tselepis C, Griffiths P, Baxter J, Thomas L, Manson J, Jenkins G. Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE). The American Journal of Gastroenterology. 106: 46-56. PMID 21157443 DOI: 10.1038/Ajg.2010.433  0.161
2003 Grover GJ, Mellström K, Ye L, Malm J, Li YL, Bladh LG, Sleph PG, Smith MA, George R, Vennström B, Mookhtiar K, Horvath R, Speelman J, Egan D, Baxter JD. Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. Proceedings of the National Academy of Sciences of the United States of America. 100: 10067-72. PMID 12888625 DOI: 10.1073/pnas.1633737100  0.154
1985 Savouret JF, Cathala G, Eberhardt NL, Miller WL, Baxter JD. Interaction of small nuclear ribonucleoproteins with simian virus 40 in CV-1 cells: is U2 snRNA involved in regulating replication? Dna (Mary Ann Liebert, Inc.). 3: 365-76. PMID 6210183 DOI: 10.1089/dna.1984.3.365  0.147
2010 Ladenson PW, Kristensen JD, Ridgway EC, Olsson AG, Carlsson B, Klein I, Baxter JD, Angelin B. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. The New England Journal of Medicine. 362: 906-16. PMID 20220185 DOI: 10.1056/NEJMoa0905633  0.143
1979 Matulich DT, Baxter JD, Gomez-Sanchez C, Holland OB. Specific binding of [3H]-16 beta-hydroxydehydroepiandrosterone by rat kidney. Journal of Steroid Biochemistry. 10: 285-9. PMID 156818 DOI: 10.1016/0022-4731(79)90254-1  0.138
1974 Baxter J, Ballard P. 165. Radioreceptor assay of natural and synthetic glucocorticoids in man Journal of Steroid Biochemistry. 5: 335. DOI: 10.1016/0022-4731(74)90310-0  0.128
1990 Shinagawa T, Do YS, Baxter JD, Carilli C, Schilling J, Hsueh WA. Identification of an enzyme in human kidney that correctly processes prorenin. Proceedings of the National Academy of Sciences of the United States of America. 87: 1927-31. PMID 2408045 DOI: 10.1073/pnas.87.5.1927  0.12
2010 Gupte AA, Liu JZ, Ren Y, Minze LJ, Wiles JR, Collins AR, Lyon CJ, Pratico D, Finegold MJ, Wong ST, Webb P, Baxter JD, Moore DD, Hsueh WA. Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice. Hepatology (Baltimore, Md.). 52: 2001-11. PMID 20938947 DOI: 10.1002/Hep.23941  0.118
1989 Sielecki AR, Hayakawa K, Fujinaga M, Murphy ME, Fraser M, Muir AK, Carilli CT, Lewicki JA, Baxter JD, James MN. Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution. Science (New York, N.Y.). 243: 1346-51. PMID 2493678 DOI: 10.1126/Science.2493678  0.105
2010 Cronin J, Williams L, McAdam E, Eltahir Z, Griffiths P, Baxter J, Jenkins G. The role of secondary bile acids in neoplastic development in the oesophagus. Biochemical Society Transactions. 38: 337-42. PMID 20298179 DOI: 10.1042/Bst0380337  0.102
1978 Baxter J, Johnson L, Lan N. 120. Rapid effects of glucocorticoids on chromatin structure Journal of Steroid Biochemistry. 9: 838. DOI: 10.1016/0022-4731(78)90820-8  0.099
1966 Baxter JD, Bondy PK. Hypercalcemia of thyrotoxicosis. Annals of Internal Medicine. 65: 429-42. PMID 4161741 DOI: 10.7326/0003-4819-65-3-429  0.097
2008 Larsen PR, Baxter JD. Cardiovascular and metabolic issues in patients with thyroid dysfunction will be highlighted at the fifth anniversary of ATA spring meetings in March 2008 Thyroid. 18: 101. PMID 18279010 DOI: 10.1089/thy.2008.0022  0.096
1980 Miller WL, Baxter JD. Recombinant DNA--a new source of insulin. Diabetologia. 18: 431-6. PMID 6252083 DOI: 10.1007/BF00261696  0.092
2021 Saxenborn P, Baxter J, Tilevik A, Fagerlind M, Dyrkell F, Pernestig AK, Enroth H, Tilevik D. Genotypic Characterization of Clinical spp. Isolates Collected From Patients With Suspected Community-Onset Sepsis, Sweden. Frontiers in Microbiology. 12: 640408. PMID 33995300 DOI: 10.3389/fmicb.2021.640408  0.087
1973 Baxter JD, Forsham PH. Tissue effects of glucocorticoids. The American Journal of Medicine. 53: 573-89. PMID 4342884 DOI: 10.1016/0002-9343(72)90154-4  0.085
2023 Cozzi-Lepri A, Dunn D, Tostevin A, Marvig RL, Bennedbaek M, Sharma S, Kozal MJ, Gompels M, Pinto AN, Lundgren J, Baxter JD. Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study. Hiv Medicine. PMID 37775947 DOI: 10.1111/hiv.13556  0.082
2000 Winters MA, Baxter JD, Mayers DL, Wentworth DN, Hoover ML, Neaton JD, Merigan TC. Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens. The Terry Beirn Community Programs for Clinical Research on AIDS. Antiviral Therapy. 5: 57-63. PMID 10846594  0.08
2007 De Luca A, Giambenedetto SD, Trotta MP, Colafigli M, Prosperi M, Ruiz L, Baxter J, Clevenbergh P, Cauda R, Perno CF, Antinori A. Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine. The Journal of Infectious Diseases. 196: 1645-53. PMID 18008248 DOI: 10.1086/522231  0.069
1979 Rousseau GG, Baxter JD. Glucocorticoids and the metabolic code. Monographs On Endocrinology. 12: 613-29. PMID 226874 DOI: 10.1007/978-3-642-81265-1_34  0.065
2005 MacArthur RD, Perez G, Walmsley S, Baxter JD, Mullin CM, Neaton JD. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy Hiv Clinical Trials. 6: 127-135. PMID 16192247 DOI: 10.1310/A9B9-Rqd7-U8Ka-503U  0.064
2006 Baxter JD, Schapiro JM, Boucher CAB, Kohlbrenner VM, Hall DB, Scherer JR, Mayers DL. Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir Journal of Virology. 80: 10794-10801. PMID 16928764 DOI: 10.1128/Jvi.00712-06  0.063
2013 Geretti AM, Fox Z, Johnson JA, Booth C, Lipscomb J, Stuyver LJ, Tachedjian G, Baxter J, Touloumi G, Lehmann C, Owen A, Phillips A. Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Plos One. 8: e69266. PMID 23874928 DOI: 10.1371/journal.pone.0069266  0.062
2003 BAXTER JD, ROSE B. The histamine content of allergic and nonallergic human nasal mucous membrane with simultaneous observations on the eosinophils. The Journal of Allergy. 24: 18-34. PMID 13022213 DOI: 10.1016/0021-8707(53)90058-6  0.06
2011 Paquet AC, Baxter J, Weidler J, Lie Y, Lawrence J, Kim R, Bates M, Coakley E, Chappey C. Differences in reversion of resistance mutations to wild-type under structured treatment interruption and related increase in replication capacity. Plos One. 6: e14638. PMID 21297946 DOI: 10.1371/journal.pone.0014638  0.057
2010 Schapiro JM, Scherer J, Boucher CA, Baxter JD, Tilke C, Perno CF, Maggiolo F, Santoro MM, Hall DB. Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score. Antiviral Therapy. 15: 1011-9. PMID 21041916 DOI: 10.3851/Imp1670  0.054
2000 Baxter JD. Advances in glucocorticoid therapy Advances in Internal Medicine. 45: 317-349. PMID 10635054  0.053
2018 Earle SA, Wright DJ, Joye S, Laffoley D, Baxter J, Safina C, Elkus P. Ocean deoxygenation: Time for action. Science (New York, N.Y.). 359: 1475-1476. PMID 29599234 DOI: 10.1126/science.aat0167  0.052
2006 Kozal MJ, Hullsiek KH, Leduc R, Novak RM, MacArthur RD, Lawrence J, Baxter JD. Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patients Antiviral Therapy. 11: 457-463. PMID 16856619  0.051
2003 Lawrence J, Mayers DL, Hullsiek KH, Collins G, Abrams DI, Reisler RB, Crane LR, Schmetter BS, Dionne TJ, Saldanha JM, Jones MC, Baxter JD. Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus. The New England Journal of Medicine. 349: 837-46. PMID 12944569 DOI: 10.1056/NEJMoa035103  0.047
2015 Adams JL, Byrne D, Pepe R, Gray A, Baxter JD. Virological failure in two patients with HIV-1 RNA viral loads >1,000,000 copies/mL initiated on elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate. Antiviral Therapy. PMID 26308882 DOI: 10.3851/IMP2987  0.046
2016 Dinges W, Girard PM, Podzamczer D, Brockmeyer NH, García F, Harrer T, Lelievre JD, Frank I, Colin De Verdière N, Yeni GP, Ortega Gonzalez E, Rubio R, Clotet Sala B, DeJesus E, Pérez-Elias MJ, ... ... Baxter JD, et al. The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. Medicine. 95: e2673. PMID 26871794 DOI: 10.1097/Md.0000000000002673  0.046
2010 Baxter JD, Kumar P, Ruane P. Enhanced susceptibility of human immunodeficiency virus type 1 to tipranavir in treatment-experienced patients Infectious Diseases in Clinical Practice. 18: 359-366. DOI: 10.1097/IPC.0b013e3181f0c036  0.043
2007 Kozal MJ, Hullsiek KH, MacArthur RD, Van Der Berg-Wolf M, Peng G, Xiang Y, Baxter JD, Uy J, Telzak EE, Novak RM. The incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategies Hiv Clinical Trials. 8: 357-370. PMID 18042501 DOI: 10.1310/hct0806-357  0.042
2014 de la Torre P, George J, Baxter JD. Nucleoside-sparing antiretroviral regimens. Current Infectious Disease Reports. 16: 410. PMID 24880455 DOI: 10.1007/s11908-014-0410-4  0.042
2008 Fox Z, Phillips A, Cohen C, Neuhaus J, Baxter J, Emery S, Hirschel B, Hullsiek KH, Stephan C, Lundgren J. Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. Aids (London, England). 22: 2279-89. PMID 18981767 DOI: 10.1097/QAD.0b013e328311d16f  0.042
2010 Baxter J, Mata EG, Thomas EJ. ChemInform Abstract: An Approach to the Synthesis of the C(17)-C(27) Fragment of Bryostatins. Cheminform. 30: no-no. DOI: 10.1002/chin.199910255  0.041
2003 Roca B, Agut H, Lawrence J, Hullsiek KH, Baxter JD, Hirschel B. Structured Treatment Interruption for Patients with Human Immunodeficiency Virus Infection [2] (multiple letters) New England Journal of Medicine. 349: 2268-2269. PMID 14657438 DOI: 10.1056/NEJM200312043492319  0.041
2011 Cozzi-Lepri A, French MA, Baxter J, Okhuysen P, Plana M, Neuhaus J, Landay A. Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial. Aids (London, England). 25: 1207-17. PMID 21505304 DOI: 10.1097/QAD.0b013e3283471f10  0.039
2020 Adams JL, Choi YC, West M, Pontiggia L, Baxter J, George J. Changes in neurocognitive assessment scores after initiating dolutegravir- versus elvitegravir-based antiretroviral therapy. Aids Care. 1-7. PMID 33103919 DOI: 10.1080/09540121.2020.1837337  0.038
2015 Jin ES, Szuszkiewicz-Garcia M, Browning JD, Baxter JD, Abate N, Malloy CR. Influence of liver triglycerides on suppression of glucose production by insulin in men. The Journal of Clinical Endocrinology and Metabolism. 100: 235-43. PMID 25250633 DOI: 10.1210/Jc.2014-2404  0.036
2011 Baxter JD, Clark RE, Samnaliev M, Leung GY, Hashemi L. Factors associated with Medicaid patients' access to buprenorphine treatment Journal of Substance Abuse Treatment. 41: 88-96. PMID 21459544 DOI: 10.1016/j.jsat.2011.02.002  0.036
2015 Clark RE, Baxter JD, Aweh G, O'Connell E, Fisher WH, Barton BA. Risk factors for relapse and higher costs among Medicaid members with opioid dependence or abuse: Opioid agonists, comorbidities, and treatment history. Journal of Substance Abuse Treatment. PMID 25997674 DOI: 10.1016/j.jsat.2015.05.001  0.035
2001 Weinstein MC, Goldie SJ, Losina E, Cohen CJ, Baxter JD, Zhang H, Kimmel AD, Freedberg KA. Use of genotypic resistance testing to guide HIV therapy: Clinical impact and cost-effectiveness Annals of Internal Medicine. 134: 440-450. PMID 11255519 DOI: 10.7326/0003-4819-134-6-200103200-00008  0.035
2007 Rachlis A, Clotet B, Baxter J, Murphy R, Lefebvre E. Safety, tolerability, and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced, hepatitis B or C co-infected patients in POWER 1 and 3. Hiv Clinical Trials. 8: 213-220. PMID 17720661 DOI: 10.1310/Hct0804-213  0.033
2011 Clark RE, Samnaliev M, Baxter JD, Leung GY. The evidence doesn't justify steps by state medicaid programs to restrict opioid addiction treatment with buprenorphine Health Affairs. 30: 1425-1433. PMID 21821560 DOI: 10.1377/hlthaff.2010.0532  0.033
2005 Novak RM, Chen L, MacArthur RD, Baxter JD, Hullsiek KH, Peng G, Xiang Y, Henely C, Schmetter B, Uy J, Van Den Berg-Wolf M, Kozal M. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: Implications for routine resistance screening before initiation of antiretroviral therapy Clinical Infectious Diseases. 40: 468-474. PMID 15668873 DOI: 10.1086/427212  0.032
2000 Baxter JD, Mayers DL, Wentworth DN, Neaton JD, Hoover ML, Winters MA, Mannheimer SB, Thompson MA, Abrams DI, Brizz BJ, Ioannidis JP, Merigan TC. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS. Aids (London, England). 14: F83-93. PMID 10894268 DOI: 10.1097/00002030-200006160-00001  0.032
2015 Baxter JD, Clark RE, Samnaliev M, Aweh G, O'Connell E. Adherence to Buprenorphine Treatment Guidelines in a Medicaid Program. Substance Abuse. 36: 174-82. PMID 25706332 DOI: 10.1080/08897077.2014.991469  0.031
2019 Largent A, Barateau A, Nunes JC, Mylona E, Castelli J, Lafond C, Greer PB, Dowling JA, Baxter J, Saint-Jalmes H, Acosta O, Crevoisier R. Comparison of deep learning-based and patch-based methods for pseudo-CT generation in MRI-based prostate dose planning. International Journal of Radiation Oncology, Biology, Physics. PMID 31505245 DOI: 10.1016/j.ijrobp.2019.08.049  0.031
2006 Lawrence J, Hullsiek KH, Thackeray LM, Abrams DI, Crane LR, Mayers DL, Jones MC, Saldanha JM, Schmetter BS, Baxter JD. Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: Final results of the CPCRA 064 study Journal of Acquired Immune Deficiency Syndromes. 43: 169-178. PMID 16951642 DOI: 10.1097/01.qai.0000242450.74779.ee  0.031
2002 Baxter JD, Merigan TC, Wentworth DN, Neaton JD, Hoover ML, Hoetelmans RM, Piscitelli SC, Verbiest WH, Mayers DL. Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapy. Aids (London, England). 16: 1131-8. PMID 12004271 DOI: 10.1097/00002030-200205240-00006  0.031
2015 Jin ES, Szuszkiewicz-Garcia M, Browning JD, Baxter JD, Abate N, Malloy CR. Influence of liver triglycerides on suppression of glucose production by insulin in men Journal of Clinical Endocrinology and Metabolism. 100: 235-243. DOI: 10.1210/jc.20142404  0.03
2009 Simen BB, Simons JF, Hullsiek KH, Novak RM, MacArthur RD, Baxter JD, Huang C, Lubeski C, Turenchalk GS, Braverman MS, Desany B, Rothberg JM, Egholm M, Kozal MJ. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes Journal of Infectious Diseases. 199: 693-701. PMID 19210162 DOI: 10.1086/596736  0.029
1997 Baxter JD, Thompson MA, MacArthur RD, Markowitz NP, Mayerc DL, LiVolsi MA, Makohon LH, Dehlincer ME, Howard SF, Neaton JD. Viral load and risk of specific opportunistic infections in patients with CD4 Counts <300 cells/mm3 enrolled in CPCRA 036 Clinical Infectious Diseases. 25: 458.  0.026
2010 Baxter JD, Bhatti L, Coakley E, Bartczak J, McDonough M, Vinisko R, Piliero PJ. Susceptibility of HIV-1 to tipranavir and other antiretroviral agents in treatment-experienced patients: The UTILIZE Study. Current Hiv Research. 8: 347-54. PMID 20353387 DOI: 10.2174/157016210791208677  0.026
2021 Fix C, Re C, Roberts B, Salzman M, Baston K, Baxter J, Gorman P, Salerno J, Haroz R. Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV. Journal of Addiction Medicine. PMID 34510089 DOI: 10.1097/ADM.0000000000000913  0.025
2015 Baxter JD, Dunn D, White E, Sharma S, Geretti AM, Kozal MJ, Johnson MA, Jacoby S, Llibre JM, Lundgren J. Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. Hiv Medicine. 16: 77-87. PMID 25711326 DOI: 10.1111/hiv.12236  0.025
2019 Largent A, Barateau A, Nunes J, Lafond C, Greer P, Dowling J, Baxter J, Saint-Jalmes H, Acosta O, de Crevoisier R. 45 A comparison of pseudo-CT generation methods for prostate MRI-based dose planning: deep learning, patch-based, atlas-based and bulk-density methods Physica Medica. 68: 28. DOI: 10.1016/j.ejmp.2019.09.126  0.024
1996 Baxter JD. The history of otolaryngology in Canada: The provincial and regional organizations concerned with standards, accreditation, and continuing medical education Journal of Otolaryngology. 25: 349-356. PMID 8902698  0.023
2008 Kim R, Baxter JD. Protease inhibitor resistance update: Where are we now? Aids Patient Care and Stds. 22: 267-277. PMID 18422460 DOI: 10.1089/apc.2007.0099  0.023
2018 Niemtzow R, Baxter J, Gallagher RM, Pock A, Calabria K, Drake D, Galloway K, Walter J, Petri R, Piazza T, Burns S, Hofmann L, Biery J, Buckenmaier C. Building Capacity for Complementary and Integrative Medicine Through a Large, Cross-Agency, Acupuncture Training Program: Lessons Learned from a Military Health System and Veterans Health Administration Joint Initiative Project. Military Medicine. PMID 29590483 DOI: 10.1093/milmed/usy028  0.022
2011 Baxter JD. A sweeter more humble man you will not meet Journal of Palliative Medicine. 14: 516-517. DOI: 10.1089/jpm.2010.0466  0.022
2009 Drummond C, Coulton S, James D, Godfrey C, Parrott S, Baxter J, Ford D, Lervy B, Rollnick S, Russell I, Peters T. Effectiveness and cost-effectiveness of a stepped care intervention for alcohol use disorders in primary care: pilot study. The British Journal of Psychiatry : the Journal of Mental Science. 195: 448-56. PMID 19880936 DOI: 10.1192/Bjp.Bp.108.056697  0.02
2014 Clark RE, Baxter JD, Barton BA, Aweh G, O'Connell E, Fisher WH. The impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts Medicaid beneficiaries with opioid dependence. Health Services Research. 49: 1964-79. PMID 25040021 DOI: 10.1111/1475-6773.12201  0.02
2008 Baxter JD, Samnaliev M, Clark RE. Patterns of health care utilization for asthma treatment in adults with substance use disorders. Journal of Addiction Medicine. 2: 79-84. PMID 21768976 DOI: 10.1097/ADM.0b013e318160e448  0.02
2009 Baxter JD. Are we providers or physicians? Archives of Internal Medicine. 169: 1725. PMID 19822834 DOI: 10.1001/archinternmed.2009.349  0.019
2012 Tevendale E, Baxter J. Heart failure comorbidities at the end of life. Current Opinion in Supportive and Palliative Care. 5: 322-6. PMID 21986912 DOI: 10.1097/SPC.0b013e32834d2ee4  0.019
2010 Ladenson PW, Kristensen JD, Ridgway EC, Olsson AG, Carlsson B, Klein I, Baxter JD, Angelin B, Marinò M. Uso dell’analogo degli ormoni tiroidei eprotirome associato alle statine nella dislipidemia L'Endocrinologo. 11: 84-84. DOI: 10.1007/BF03344705  0.017
2013 Clark RE, Baxter JD. Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good? Jama Internal Medicine. 173: 1571-2. PMID 23877740 DOI: 10.1001/jamainternmed.2013.9059  0.017
1997 Baxter JD. The history of otolaryngology in Canada: University of Ottawa The Journal of Otolaryngology. 26: 290-292. PMID 9263904  0.017
2001 Bruneau S, Ayukawa H, Proulx JF, Baxter JD, Kost K. Longitudinal observations (1987-1997) on the prevalence of middle ear disease and associated risk factors among Inuit children of Inukjuak, Nunavik, Quebec, Canada International Journal of Circumpolar Health. 60: 632-639. PMID 11768445  0.017
1997 Manders SM, Baxter JD. Granuloma inguinale and HIV: A unique presentation and novel treatment regimen Journal of the American Academy of Dermatology. 37: 494-496. PMID 9308572 DOI: 10.1016/S0190-9622(97)70158-0  0.017
2008 Herrin BS, Baxter JD. Outsourcing HIM functions to Europe Journal of the American Health Information Management Association. 79: 56-57+62. PMID 18833844  0.016
1996 Baxter JD. The history of otolaryngology in Canada: University of Manitoba Journal of Otolaryngology. 25: 423-426. PMID 8972439  0.016
1997 Baxter JD, Attia EL. The history of otolaryngology in Canada: Dalhousie University The Journal of Otolaryngology. 26: 351-355. PMID 9343778  0.016
1997 Baxter JD. The history of otolaryngology in Canada: University of Sherbrooke The Journal of Otolaryngology. 26: 293-294. PMID 9263905  0.016
1996 Baxter JD. History of otolaryngology in Canada, McGill University: Part 1 Journal of Otolaryngology. 25: 49-58. PMID 8816112  0.016
1996 Baxter JD. History of otolaryngology in Canada, McGill University: Part 2 Journal of Otolaryngology. 25: 130-135. PMID 8683654  0.016
1997 Baxter JD. The history of otolaryngology in Canada: Laval University Journal of Otolaryngology. 26: 215-219. PMID 9176810  0.015
1998 Baxter JD. The history of otolaryngology in Canada: University of Montreal Journal of Otolaryngology. 27: 55-0. PMID 9511122  0.015
1998 Baxter JD, Oldring DJ. The history of otolaryngology in Canada: University of Alberta The Journal of Otolaryngology. 27: 115-119. PMID 9572467  0.015
2009 Clark RE, Weir S, Ouellette RA, Zhang J, Baxter JD. Beyond health plans: behavioral health disorders and quality of diabetes and asthma care for Medicaid beneficiaries. Medical Care. 47: 545-52. PMID 19319000 DOI: 10.1097/MLR.0b013e318190db45  0.015
2003 TREMBLE GE, BAXTER JD. Otitis externa; a controversial subject. A.M.a. Archives of Otolaryngology. 56: 241-9. PMID 12984916 DOI: 10.1001/archotol.1952.00710020261002  0.015
2004 Potteiger CE, Mitchell S, Baro S, Komar M, Baxter J, Brunner MI. SPLENIC RUPTURE FOLLOWING COLONOSCOPY TREATED SUCCESSFULLY WITH SPLENIC ARTERY EMBOLIZATION American Journal of Gastroenterology. 99: S179-S180. DOI: 10.14309/00000434-200410001-00549  0.014
2014 Baxter JD. The final breath. The American Journal of Hospice & Palliative Care. 31: 788. PMID 23943632 DOI: 10.1177/1049909113499605  0.014
2021 Levy S, Cole G, Pabari P, Dani M, Barton C, Mayet J, McDonagh T, Baxter J, Plymen C. New horizons in cardiogeriatrics: geriatricians and heart failure care-the custard in the tart, not the icing on the cake. Age and Ageing. PMID 33837764 DOI: 10.1093/ageing/afab057  0.013
2013 Lin JZ, Martagón AJ, Hsueh WA, Baxter JD, Gustafsson JÅ, Webb P, Phillips KJ, Centanni M, Cellini M. Gli agonisti del recettore degli ormoni tiroidei riducono i livelli sierici di colesterolo indipendentemente dall’azione sui recettori delle LDL L'Endocrinologo. 14: 91-91. DOI: 10.1007/BF03346053  0.013
2008 Winters B, Montaner J, Harrigan PR, Gazzard B, Pozniak A, Miller MD, Emery S, Van Leth F, Robinson P, Baxter JD, Perez-Elias M, Castor D, Hammer S, Rinehart A, Vermeiren H, et al. Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data Journal of Acquired Immune Deficiency Syndromes. 48: 26-34. PMID 18360290 DOI: 10.1097/QAI.0b013e31816d9bf4  0.013
1997 Baxter JD. The History of Otolaryngology in Canada: University of Western Ontario Journal of Otolaryngology. 26: 70-73. PMID 9055179  0.012
1997 Baxter JD. The history of otolaryngology in Canada: the University of British Columbia The Journal of Otolaryngology. 26: 143-146. PMID 9106093  0.011
2016 Baxter J, Lyng KA, Askham C, Hanssen OJ. High-quality collection and disposal of WEEE: Environmental impacts and resultant issues. Waste Management (New York, N.Y.). PMID 26873014 DOI: 10.1016/j.wasman.2016.02.005  0.011
2008 Baxter JD, Samnaliev M, Clark RE. Patterns of health care utilization for asthma treatment in adults with substance use disorders Journal of Addiction Medicine. 2: 79-84. DOI: 10.1097/ADM.0b013e318160e448  0.011
2022 Lous ML, Baxter J, Timoh KN. Madame Angélique du Coudray: pioneer of medical simulation and unsung hero. Journal of Gynecology Obstetrics and Human Reproduction. 102529. PMID 36566930 DOI: 10.1016/j.jogoh.2022.102529  0.01
2014 Baxter JD, McCourt C, Jarrett PM. What is current practice in offering debriefing services to post partum women and what are the perceptions of women in accessing these services: a critical review of the literature. Midwifery. 30: 194-219. PMID 24491690 DOI: 10.1016/j.midw.2013.12.013  0.01
2012 Baxter JD. The scream Journal of Palliative Medicine. 15: 247. PMID 22339332 DOI: 10.1089/jpm.2011.0247  0.01
2012 Baxter J, McDonagh T. Can geriatricians improve inpatient heart failure care? Time for a heart to heart. Age and Ageing. 41: 140-1. PMID 22217459 DOI: 10.1093/ageing/afr150  0.01
2011 Weir S, Posner HE, Zhang J, Jones WC, Willis G, Baxter JD, Clark RE. Disparities in routine breast cancer screening for Medicaid managed care members with a work-limiting disability. Medicare & Medicaid Research Review. 1. PMID 22340778 DOI: 10.5600/mmrr.001.04.a02  0.01
2011 Weir S, Posner HE, Zhang J, Willis G, Baxter JD, Clark RE. Predictors of Prenatal and Postpartum Care Adequacy in a Medicaid Managed Care Population Women's Health Issues. 21: 277-285. PMID 21565526 DOI: 10.1016/j.whi.2011.03.001  0.01
2011 Cronin J, McAdam E, Danikas A, Tselepis C, Griffiths P, Baxter J, Thomas L, Manson J, Jenkins G. What's Hot in the Red Journal This Month The American Journal of Gastroenterology. 106: 1-3. DOI: 10.1038/ajg.2010.486  0.01
2010 Baxter JD. Air versus water. Annals of Internal Medicine. 153: 616-7. PMID 21041584 DOI: 10.7326/0003-4819-153-9-201011020-00015  0.01
2010 Lundgren JD, Baxter J, Deeks SG, Lane HC. Biomarkers in HIV disease. Current Opinion in Hiv and Aids. 5: 459-62. PMID 20978387 DOI: 10.1097/COH.0b013e32833f2ed6  0.01
2010 Baxter J. Editorial: The place of bariatric surgery in the new decade British Journal of Hospital Medicine. 71: 304-305. PMID 20551865  0.01
2009 Baxter JD. A son's remembrance American Journal of Hospice and Palliative Medicine. 26: 500-501. PMID 19923633 DOI: 10.1177/1049909109338356  0.01
2009 Samnaliev M, Baxter JD, Clark RE. Comparative evaluation of two asthma care quality measures among medicaid beneficiaries Chest. 135: 1193-1196. PMID 19118265 DOI: 10.1378/chest.07-2962  0.01
2009 Baxter JD, Samnaliev M, Clark RE. The quality of asthma care among adults with substance-related disorders and adults with mental illness Psychiatric Services. 60: 43-49. PMID 19114569 DOI: 10.1176/appi.ps.60.1.43  0.01
2009 Clark RE, Weir S, Ouellette RA, Zhang J, Baxter JD. Beyond health plans: Behavioral health disorders and quality of diabetes and asthma care for medicaid beneficiaries Medical Care. 47: 545-552. DOI: 10.1097/MLR.0b013e318190db45  0.01
2008 Baxter J. Obesity surgery. Lancet (London, England). 371: 557. PMID 18280323 DOI: 10.1016/S0140-6736(08)60264-0  0.01
2006 Baxter JD. The experts speak. New issues in the challenge of HIV drug resistance. Interview by Vicki Glaser. Aids Patient Care and Stds. 20: 737-740. PMID 17134347 DOI: 10.1089/apc.2006.20.737  0.01
2006 Niemtzow RC, Gambel J, Helms J, Pock A, Burns SM, Burns S, Baxter J. Integrating ear and scalp acupuncture techniques into the care of blast-injured United States military service members with limb loss. Journal of Alternative and Complementary Medicine (New York, N.Y.). 12: 596-9. PMID 16970527 DOI: 10.1089/acm.2006.12.596  0.01
2006 Baxter JD. Historical overview of the McGill Baffin Program, 1964-1997. International Journal of Circumpolar Health. 65: 91-95. PMID 16544651  0.01
2004 Lee K, Hu P, Blows JL, Thorncraft D, Baxter J. 200-m optical fiber with an integrated electrode and its poling. Optics Letters. 29: 2124-6. PMID 15460877 DOI: 10.1364/ol.29.002124  0.01
2002 Ganeshan A, Soonawalla Z, De M, Baxter J. Intravascular lymphoma: a diagnostic enigma. Journal of the Royal Society of Medicine. 95: 37-8. PMID 11773352  0.01
1999 Baxter JD. Otitis media in Inuit children in the Eastern Canadian Arctic - An overview - 1968 to date International Journal of Pediatric Otorhinolaryngology. 49: 165-168. PMID 10577798 DOI: 10.1016/S0165-5876(99)00154-8  0.01
1999 Baxter JD, Hare GT. Chronic disseminated infection and intravesical bacillus Calmette-Guerin New Jersey Medicine : the Journal of the Medical Society of New Jersey. 96: 50-52. PMID 9949659  0.01
1997 Reboli AC, Lukac SM, Baxter JD, Chernoff D, Hayden FG. The serologic response and late effects on viral load and CD4 count of influenza vaccination in HIV-infected patients with CD4 counts >200 Clinical Infectious Diseases. 25: 450.  0.01
1996 Baxter JD. The typhus group Clinics in Dermatology. 14: 271-278. PMID 8727129 DOI: 10.1016/0738-081X(96)00011-9  0.01
1995 Ortiz JM, Kamerling JM, Fischer D, Baxter J. Scleritis, uveitis, and glaucoma in a patient with rheumatic fever American Journal of Ophthalmology. 120: 538-539. PMID 7573320 DOI: 10.1016/S0002-9394(14)72676-5  0.01
1965 Baxter JD. LXVI: Glomus Tumor (Chemodectoma) of the Larynx Annals of Otology, Rhinology &Amp; Laryngology. 74: 813-820. PMID 4284860 DOI: 10.1177/000348946507400319  0.01
Hide low-probability matches.